[go: up one dir, main page]

CN101495101B - Sugar-coated preparation and its manufacturing method - Google Patents

Sugar-coated preparation and its manufacturing method Download PDF

Info

Publication number
CN101495101B
CN101495101B CN2007800281535A CN200780028153A CN101495101B CN 101495101 B CN101495101 B CN 101495101B CN 2007800281535 A CN2007800281535 A CN 2007800281535A CN 200780028153 A CN200780028153 A CN 200780028153A CN 101495101 B CN101495101 B CN 101495101B
Authority
CN
China
Prior art keywords
sugar
coated
coating
methyl methacrylate
ethyl acrylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800281535A
Other languages
Chinese (zh)
Other versions
CN101495101A (en
Inventor
下川达张
川岛弘行
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of CN101495101A publication Critical patent/CN101495101A/en
Application granted granted Critical
Publication of CN101495101B publication Critical patent/CN101495101B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明提供短时间且简单制造具有充分硬度、且低吸湿性、防臭性、崩解性优异的糖衣制剂的技术。具体地说,本发明提供在使用同时进行糖衣液的喷雾工序及干燥工序的连续包衣法的糖衣制剂的制造中可优选使用的糖衣液、具有由该糖衣液形成的糖衣层的糖衣制剂及其制造方法。本发明使用下述糖衣液制造糖衣制剂,所述糖衣液为含有丙烯酸乙酯/甲基丙烯酸甲酯共聚物及溶剂的糖衣液,丙烯酸乙酯/甲基丙烯酸甲酯共聚物的浓度相对于总固态成分为0.01~10重量%。

Figure 200780028153

The present invention provides a technique for producing sugar-coated preparations having sufficient hardness in a short time and easily, and having excellent low hygroscopicity, deodorant properties, and disintegration properties. Specifically, the present invention provides a sugar-coating solution that can be preferably used in the production of a sugar-coated preparation using a continuous coating method that simultaneously performs a spraying step and a drying step of the sugar-coating solution, a sugar-coated preparation having a sugar-coated layer formed of the sugar-coating solution, and its method of manufacture. The present invention uses the following sugar-coating solution to manufacture sugar-coated preparations, the sugar-coating solution is a sugar-coating solution containing ethyl acrylate/methyl methacrylate copolymer and a solvent, and the concentration of ethyl acrylate/methyl methacrylate copolymer is relative to the total The solid content is 0.01 to 10% by weight.

Figure 200780028153

Description

糖衣制剂及其制造方法Sugar-coated preparation and its manufacturing method

技术领域 technical field

本发明涉及糖衣制剂及其制造方法。The present invention relates to a sugar-coated preparation and a method for its manufacture.

背景技术 Background technique

糖衣制剂由于其糖衣层具有防止氧、水、难闻成分透过的功能,因此低透氧性、低吸湿性、防臭性优异,是适于配伍在素片中的成分的稳定化的剂型。Sugar-coated preparations have low oxygen permeability, low hygroscopicity, and excellent deodorant properties because the sugar-coated layer has the function of preventing the permeation of oxygen, water, and unpleasant ingredients. It is a dosage form suitable for stabilizing ingredients mixed in plain tablets.

例如大蒜加工物除了恢复疲劳、滋补强壮效果之外,还具有增强胃收缩力、促进新陈代谢作用、促进血液循环作用、保肝作用等,作为药品被广泛使用,但由于受到热量或水分的影响而产生难闻气味,因此多数进行糖衣制剂化。For example, in addition to fatigue recovery and nourishing and strengthening effects, garlic processed products also have the effects of enhancing gastric contractility, promoting metabolism, promoting blood circulation, and protecting the liver. They are widely used as medicines, but they are affected by heat or moisture. Since it produces an unpleasant smell, it is made into a sugar-coated formulation in many cases.

另外,氯化甲基甲硫氨酸锍(Methylmethioninesulfonium chloride以下也称作“MMSC”。)具有改善胃溃疡、十二指肠溃疡、胃炎等自觉症状及他觉症状、改善慢性肝脏疾病的肝功能等诸多症状的缓解作用,作为药品被广泛使用。但是,MMSC由于具有因吸收空气中的水分而分解的性质,因此含有MMSC的制剂具有产生难闻气味、变色、有效成分含量降低等品质下降的问题。因而,为了防止吸湿,多数MMSC制剂进行糖衣制剂化(专利文献1、2)。In addition, methylmethioninesulfonium chloride (Methylmethioninesulfonium chloride is also referred to as "MMSC" hereafter.) can improve the subjective symptoms and other symptoms such as gastric ulcer, duodenal ulcer, gastritis, and improve the liver function of chronic liver disease. It is widely used as a medicine for the relief of many symptoms. However, since MMSC has the property of decomposing by absorbing moisture in the air, preparations containing MMSC have problems such as generation of unpleasant odor, discoloration, and decrease in the content of active ingredients. Therefore, in order to prevent moisture absorption, many MMSC preparations are sugar-coated (Patent Documents 1 and 2).

另外,丙戊酸钠作为小发作·部分性发作·精神运动性发作及混合发作等各种癫痫、伴随癫痫的性格行为障碍(不满·易怒性等)以及躁狂及躁郁性疾病的躁狂状态治疗用药品被广泛使用。但是,丙戊酸钠具有吸湿性和潮解性,为了防止开封后的品质降低进行糖衣制剂化(专利文献3、4)。In addition, sodium valproate is used as a treatment for various types of epilepsy such as petit mal seizures, partial seizures, psychomotor seizures, and mixed seizures, as well as personality and behavioral disorders (dissatisfaction, irritability, etc.) Drugs for the treatment of madness are widely used. However, sodium valproate has hygroscopicity and deliquescent properties, and sugar-coated formulations were performed in order to prevent quality deterioration after opening (patent documents 3 and 4).

糖衣制剂一般来说通过重复数次[1]糖衣液的喷雾、[2]蒸发、[3]干燥而制造(例如专利文献5)。其中,[2]蒸发是将糖衣制剂的侧面部完全地包埋,用于将喷雾的糖衣液均匀地扩展在素片上的工序,当使用通常具有高粘度的糖衣液时,是不可缺少的工序。另一方面,含有该工序的糖衣制剂的制造方法需要非常长的操作时间,具有相对于素片需要大量糖衣液等的缺点。A sugar-coated preparation is generally manufactured by repeating [1] spraying of a sugar-coating solution, [2] evaporation, and [3] drying several times (for example, Patent Document 5). Among them, [2] Evaporation is the process of completely covering the side of the sugar-coated preparation and spreading the sprayed sugar-coated liquid evenly on the plain tablet. When using a sugar-coated liquid that usually has a high viscosity, it is an indispensable process. . On the other hand, the production method of the sugar-coated preparation including this step requires a very long operation time, and has disadvantages such as requiring a large amount of sugar-coated liquid for plain tablets.

作为克服上述不利方面的制造方法,如薄膜包衣片的制造那样,研究了通过在喷雾包衣液的同时进行干燥形成包衣层的方法((以下也称作连续包衣法。)形成糖衣层的方法。连续包衣法中,由于必须将喷雾的糖衣液迅速、均匀地扩展在素片等芯材上,因此需要稀释糖衣液降低粘度。因此,开发了例如使用混悬有糖和滑石粉的糖衣液形成薄层糖衣层的技术等(专利文献6)。但是,这种薄层糖衣层与现有品相比具有强度差的问题。另外,作为改善薄层糖衣层的强度的方法,还开发了例如在薄膜包衣片和糖衣层之间设置中间层的技术等(专利文献7)。但是,这种方法由于包括调制、喷雾具有与糖衣层不同组成的包衣液,因此很难说其足够简单。另外,还开发了代替通常作为粘合剂使用的阿拉伯胶或明胶,使用羟丙基甲基纤维素或羟基丙基纤维素,降低糖衣液粘度的技术(专利文献8)。但是,通过该方法获得的糖衣层具有致密性不充分,作为糖衣制剂特征的低透氧性、低吸湿性、防臭性差的问题。As a production method to overcome the disadvantages described above, as in the production of film-coated tablets, a method of forming a coating layer by drying while spraying a coating solution (hereinafter also referred to as a continuous coating method) has been studied to form a sugar coating. The method of layer.In the continuous coating method, since the sugar-coated liquid of spraying must be expanded rapidly and evenly on the core materials such as plain tablets, it is necessary to dilute the sugar-coated liquid to reduce the viscosity.Therefore, for example, the use of suspended sugar and talc has been developed. The technology etc. (patent document 6) that the sugar-coating liquid of powder forms thin-layer sugar-coating layer.But, this thin-layer sugar-coating layer has the problem that strength is poor compared with existing product.In addition, as the method for improving the intensity of thin-layer sugar-coating layer , have also developed such as the technology of setting an intermediate layer between a film-coated tablet and a sugar-coated layer (Patent Document 7). However, this method is very difficult because it includes preparation and spraying of a coating solution having a composition different from that of the sugar-coated layer. It is hard to say that it is simple enough. In addition, instead of gum arabic or gelatin, which are usually used as binders, a technology has been developed to reduce the viscosity of the sugar coating solution by using hydroxypropylmethylcellulose or hydroxypropylcellulose (Patent Document 8). However, the sugar-coated layer obtained by this method has problems of insufficient compactness, low oxygen permeability, low hygroscopicity, and poor deodorization properties characteristic of sugar-coated preparations.

如此,对于糖衣制剂的制造方法或糖衣液虽然从操作性和制剂特性的改善两方面进行了各种研究,但仍未开发出共同改善两者的技术。Thus, although various researches have been conducted on the production method of sugar-coated preparations and sugar-coated liquids in terms of both operability and improvement of preparation properties, no technology has been developed to jointly improve both.

【专利文献1】特开2003-63953号公报[Patent Document 1] JP-A-2003-63953

【专利文献2】特开2003-95928号公报[Patent Document 2] JP-A-2003-95928

【专利文献3】特开2006-256961号公报[Patent Document 3] JP-A-2006-256961

【专利文献4】特开平04-235914号公报[Patent Document 4] Japanese Patent Laid-Open Publication No. 04-235914

【专利文献5】特开平06-292511号公报[Patent Document 5] Japanese Patent Laid-Open Publication No. 06-292511

【专利文献6】特开昭56-87518号公报[Patent Document 6] JP-A-56-87518

【专利文献7】特开2004-155656号公报[Patent Document 7] JP-A-2004-155656

【专利文献8】特开昭49-133515号公报[Patent Document 8] JP-A-49-133515

发明内容 Contents of the invention

本发明的课题在于提供具有充分硬度、短时间且简单地制造低吸湿性、防臭性、崩解性优异的糖衣制剂的技术。具体地说,本发明的课题在于提供能够优选用于使用了同时进行糖衣液的喷雾工序和干燥工序的连续包衣法的糖衣制剂制造的糖衣液、具有由该糖衣液形成的糖衣层的糖衣制剂及其制造方法。An object of the present invention is to provide a technique for easily producing a sugar-coated preparation having sufficient hardness, low hygroscopicity, deodorization, and disintegration in a short period of time. Specifically, an object of the present invention is to provide a sugar-coating solution that can be preferably used in the production of a sugar-coating preparation using a continuous coating method that simultaneously performs a spraying process and a drying process of the sugar-coating solution, and a sugar-coating solution having a sugar-coating layer formed of the sugar-coating solution. Formulations and methods for their manufacture.

本发明人等对适于连续包衣法的糖衣液的组成进行了各种研究。而且发现在含糖的溶剂中以特定比例配合了丙烯酸乙酯/甲基丙烯酸甲酯共聚物的糖衣液具有适于连续包衣法的物性、以及具有利用糖衣液的连续包衣法形成的糖衣层的糖衣制剂具备低吸湿性、防臭性及良好的崩解性,进而完成本发明,所述连续包衣法使用具有上述组成的包衣液。The inventors of the present invention conducted various studies on the composition of the sugar coating solution suitable for the continuous coating method. Furthermore, it has been found that a sugar-coating liquid in which ethyl acrylate/methyl methacrylate copolymer is blended in a specific ratio in a sugar-containing solvent has physical properties suitable for a continuous coating method, and that a sugar-coating liquid formed by a continuous coating method using a sugar-coating liquid The sugar-coated preparation of the first layer has low hygroscopicity, deodorization and good disintegration properties, and further completes the present invention. The continuous coating method uses a coating solution having the above-mentioned composition.

即,本发明提供一种含有糖、丙烯酸乙酯/甲基丙烯酸甲酯共聚物及溶剂的糖衣液,其中,丙烯酸乙酯/甲基丙烯酸甲酯共聚物的浓度相对于总固态成分为0.01~10重量%,使用该糖衣液制造糖衣制剂的方法以及通过该制造方法获得的糖衣制剂。That is, the present invention provides a sugar coating solution containing sugar, ethyl acrylate/methyl methacrylate copolymer and solvent, wherein the concentration of ethyl acrylate/methyl methacrylate copolymer is 0.01 to 10% by weight, a method for producing a sugar-coated preparation using the sugar-coating liquid, and a sugar-coated preparation obtained by the production method.

附图说明 Description of drawings

【图1】表示时间经过和糖衣制剂的吸湿率变化的图。[ Fig. 1 ] A graph showing changes in moisture absorption rate of sugar-coated preparations over time.

【图2】表示时间经过和含大蒜加工物的糖衣制剂的吸湿率变化的图。[ Fig. 2 ] A graph showing changes in time and moisture absorption rate of sugar-coated preparations containing processed garlic products.

【图3】表示时间经过和含MMSC的糖衣制剂的吸湿率变化的图。[ Fig. 3] Fig. 3 is a graph showing changes in moisture absorption rate of sugar-coated preparations containing MMSC over time.

【图4】表示时间经过和含丙戊酸钠的糖衣制剂的吸湿率变化的图。[ Fig. 4] Fig. 4 is a graph showing changes in moisture absorption rate of sugar-coated formulations containing sodium valproate over time.

【图5】表示时间经过和丙戊酸钠的溶出率变化的图。[ Fig. 5 ] A graph showing changes in the dissolution rate of sodium valproate over time.

具体实施方式 Detailed ways

本发明的糖衣液含有糖、丙烯酸乙酯/甲基丙烯酸甲酯共聚物及溶剂。The sugar coating liquid of the present invention contains sugar, ethyl acrylate/methyl methacrylate copolymer and solvent.

本发明中使用的糖只要是通常糖衣制剂的糖衣层形成所使用的糖则可没有特别限定地使用,例如可以举出砂糖、精制白糖、白糖、葡萄糖、海藻糖等。其中,可以优选使用砂糖、精制白糖、白糖。The sugar used in the present invention is not particularly limited as long as it is generally used for forming a sugar coating layer of sugar coating preparations, and examples thereof include granulated sugar, refined white sugar, white sugar, glucose, trehalose, and the like. Among them, granulated sugar, refined white sugar, and white sugar can be preferably used.

本发明的糖衣液中,糖的配合量并无特别限定,通常可以为10~85重量%、优选可以为10~70重量%、更优选可以为15~60重量%。In the sugar-coating solution of the present invention, the compounding amount of sugar is not particularly limited, but may be usually 10 to 85% by weight, preferably 10 to 70% by weight, more preferably 15 to 60% by weight.

本发明中使用的丙烯酸乙酯/甲基丙烯酸甲酯共聚物是指丙烯酸乙酯和甲基丙烯酸甲酯共聚的聚合物。共聚物的数均分子量只要是能够赋予糖衣制剂适当的硬度和崩解性的范围即可,通常为10,000~1,500,000、优选为400,000~1,200,000、更优选为500,000~1,100,000。另外,构成共聚物的丙烯酸乙酯与甲基丙烯酸甲酯的摩尔比通常为10∶1~1∶10、优选为4∶1~1∶4、更优选为3∶1~1∶3。另外,共聚物的玻璃转移温度通常为-40~30℃、优选为-30~20℃、更优选为-20~10℃的范围。The ethyl acrylate/methyl methacrylate copolymer used in the present invention refers to a polymer in which ethyl acrylate and methyl methacrylate are copolymerized. The number average molecular weight of the copolymer may be within a range that can impart appropriate hardness and disintegratability to the sugar-coated preparation, and is usually 10,000 to 1,500,000, preferably 400,000 to 1,200,000, more preferably 500,000 to 1,100,000. In addition, the molar ratio of ethyl acrylate and methyl methacrylate constituting the copolymer is usually 10:1 to 1:10, preferably 4:1 to 1:4, more preferably 3:1 to 1:3. Moreover, the glass transition temperature of a copolymer is -40-30 degreeC normally, Preferably it is -30-20 degreeC, More preferably, it is the range of -20-10 degreeC.

丙烯酸乙酯/甲基丙烯酸甲酯共聚物可以通过根据常规方法共聚丙烯酸乙酯和甲基丙烯酸甲酯而获得。另外,丙烯酸乙酯/甲基丙烯酸甲酯共聚物可以使用市售品。市售品可以举出例如使用作为表面活性剂将丙烯酸乙酯/甲基丙烯酸甲酯共聚物分散于水中的乳浊液的オイドラギツトNE30D(樋ロ商会)、コリコ一トEMM30D(BASFジヤパン)等。The ethyl acrylate/methyl methacrylate copolymer can be obtained by copolymerizing ethyl acrylate and methyl methacrylate according to a conventional method. In addition, a commercial item can be used for an ethyl acrylate/methyl methacrylate copolymer. Commercially available products include, for example, Oidragit NE30D (Hiro Shokai) and Koricott EMM30D (BASF Japan) using an emulsion obtained by dispersing an ethyl acrylate/methyl methacrylate copolymer in water as a surfactant.

本发明的糖衣液中,丙烯酸乙酯/甲基丙烯酸甲酯共聚物的配合量相对于糖衣液中所含总固态成分为0.01~10重量%。其中,优选为0.1~8重量%。配合量超过10重量%时,则会发生混悬于糖衣液中的固态成分的凝集,不优选。In the sugar-coating liquid of the present invention, the blending amount of the ethyl acrylate/methyl methacrylate copolymer is 0.01 to 10% by weight relative to the total solid content contained in the sugar-coating liquid. Among them, 0.1 to 8% by weight is preferable. When the compounding amount exceeds 10% by weight, aggregation of solid components suspended in the sugar-coating liquid occurs, which is not preferable.

本发明的糖衣液中,丙烯酸乙酯/甲基丙烯酸甲酯共聚物和糖的质量比通常为1∶1~1∶10,000、优选为1∶3~1∶1,000、更优选为1∶5~1∶500。In the sugar coating solution of the present invention, the mass ratio of ethyl acrylate/methyl methacrylate copolymer to sugar is usually 1:1 to 1:10,000, preferably 1:3 to 1:1,000, more preferably 1:5 to 1:500.

本发明的糖衣液的溶剂只要是通常糖衣液中使用的溶剂则无特别限定。例如可以举出水、乙醇、异丙醇等低级醇、丙酮或它们的混合物。这些溶剂中,通常优选使用精制水。The solvent of the sugar-coating solution of the present invention is not particularly limited as long as it is a solvent generally used for a sugar-coating solution. Examples thereof include water, lower alcohols such as ethanol and isopropanol, acetone, or mixtures thereof. Among these solvents, purified water is usually preferably used.

糖衣液中的溶剂配合量并无特别限定,通常为15~90重量%、优选为15~85重量%、更优选为20~80重量%。溶剂的配合量超过90重量%时,用于形成糖衣层的操作时间延长,同时难以形成致密的糖衣层,影响芯材所含药物的稳定性。另外,小于15重量%时,糖衣液的粘性会增高,发生片剂会附着在片剂包衣装置的锅中等操作性问题,另外,利用连续包衣法制造糖衣制剂时,不能在片剂表面上均匀地延展糖衣液、无法形成均匀厚度的糖衣层。另外,糖衣液的粘度只要是可以利用制造糖衣制剂所用装置进行喷雾的范围即可,还可以调整溶剂的配合量使得其粘度通常为3~1,000cp、优选为5~700cp、更优选为10~400cp。The compounding quantity of the solvent in a sugar-coating liquid is not specifically limited, Usually, it is 15-90 weight%, Preferably it is 15-85 weight%, More preferably, it is 20-80 weight%. When the compounding amount of the solvent exceeds 90% by weight, the operation time for forming the sugar-coat layer is prolonged, and it is difficult to form a dense sugar-coat layer, which affects the stability of the drug contained in the core material. In addition, when it is less than 15% by weight, the viscosity of the sugar-coating solution will increase, and there will be operational problems such as the tablet will adhere to the pan of the tablet coating device. In addition, when the sugar-coated preparation is produced by the continuous coating method, it cannot Spread the icing liquid evenly on the top, and it is impossible to form a icing layer of uniform thickness. In addition, the viscosity of the sugar-coating solution should be within the range that can be sprayed by the equipment used to manufacture the sugar-coating preparation, and the compounding amount of the solvent can be adjusted so that the viscosity is usually 3 to 1,000 cp, preferably 5 to 700 cp, more preferably 10 to 700 cp. 400cp.

本发明的糖衣液中除了上述各成分之外,还可以根据需要配合作为药品添加物允许、且可口服的各种任意成分。作为这种添加剂,例如可以举出涂布剂、着色剂和光泽化剂等。In addition to the above-mentioned components, the sugar-coated solution of the present invention may also contain various optional components that are permitted as pharmaceutical additives and that can be taken orally as needed. Examples of such additives include coating agents, colorants, and gloss agents.

作为包衣剂,例如可以举出羟丙基纤维素、羟丙基甲基纤维素2910、羟丙基甲基纤维素2208、甲基纤维素、聚乙烯醇、聚乙烯吡咯烷酮、结晶纤维素、阿拉伯胶粉末、精制虫胶、支链淀粉、沉降碳酸钙、滑石粉、磷酸氢钙、轻质硅酸酐、含水二氧化硅、氧化钛、磷酸二氢钠、氢化油、单硬脂酸甘油酯及聚乙二醇单硬脂酸酯等,其配合量相对于糖衣液优选为0~80重量%。Examples of coating agents include hydroxypropylcellulose, hydroxypropylmethylcellulose 2910, hydroxypropylmethylcellulose 2208, methylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, crystalline cellulose, Gum Arabic Powder, Refined Shellac, Pullulan, Precipitated Calcium Carbonate, Talc, Dicalcium Phosphate, Light Silicic Anhydride, Hydrous Silica, Titanium Oxide, Sodium Dihydrogen Phosphate, Hydrogenated Oil, Glyceryl Monostearate and polyethylene glycol monostearate, etc., the compounding amount thereof is preferably 0 to 80% by weight relative to the sugar-coating solution.

着色剂例如可以举出各种食用色素、焦油色素及三氧化二铁等,其配合量相对于糖衣制剂优选为0.1重量%以下。Examples of coloring agents include various food colorings, tar colorings, ferric oxide, and the like, and the compounding amount thereof is preferably 0.1% by weight or less with respect to the sugar-coated preparation.

光泽化剂例如可以举出巴西棕榈蜡或蜜蜡等,其配合量相对于糖衣制剂优选为0.1重量%以下。Examples of gloss agents include carnauba wax, beeswax, and the like, and the compounding amount thereof is preferably 0.1% by weight or less with respect to the sugar-coating preparation.

另外,本发明的糖衣液的粘度通常为3~1,000cp、优选为5~700cp、更优选为10~400cp。使用这种范围粘度的糖衣液时,即便在利用连续包衣法制造糖衣制剂时,也容易形成均匀的糖衣层。Moreover, the viscosity of the sugar-coating liquid of this invention is 3-1,000 cp normally, Preferably it is 5-700 cp, More preferably, it is 10-400 cp. When using a sugar-coating liquid having a viscosity in this range, it is easy to form a uniform sugar-coating layer even when a sugar-coated preparation is produced by a continuous coating method.

本发明的糖衣液可以通过将糖、丙烯酸乙酯/甲基丙烯酸甲酯共聚物及必要的上述任意成分混悬于溶剂而制造。此时,为了将丙烯酸乙酯/甲基丙烯酸甲酯共聚物充分地分散在溶剂中,还优选添加表面活性剂。The sugar coating solution of the present invention can be produced by suspending sugar, ethyl acrylate/methyl methacrylate copolymer, and necessary optional components described above in a solvent. At this time, it is also preferable to add a surfactant in order to sufficiently disperse the ethyl acrylate/methyl methacrylate copolymer in the solvent.

本发明的糖衣制剂在含有药物的芯材的周围具有至少1层使用本发明糖衣液形成的糖衣层。The sugar-coated preparation of the present invention has at least one sugar-coated layer formed using the sugar-coating solution of the present invention around a drug-containing core material.

本发明的糖衣制剂所含的含有药物的芯材可以举出素片或芯颗粒。即,本发明的糖衣制剂例如可以制成糖衣片或糖衣颗粒的剂型。The drug-containing core material contained in the sugar-coated preparation of the present invention includes plain tablets or core granules. That is, the sugar-coated preparation of the present invention can be prepared, for example, in the form of sugar-coated tablets or sugar-coated granules.

本发明中,芯材所含有的药物为确认了口服给药的安全性的药物,只要适于糖衣制剂则无特别限定,优选可以举出具有不愉快气味的药物、在水中不稳定的药物、产生须晶的药物等。例如,作为具有不愉快气味的药物可以举出生药(オキソアミヂン末、啤酒花、薏仁、当药、人参、黄芪、茴香、丁香、生姜及颠茄浸膏等)、大蒜加工物、氯化甲基甲硫氨酸锍、L-半胱氨酸及维生素B1类等,作为在水中不稳定的药物可以举出各种维生素(维生素A类、维生素B1类、维生素B2类、维生素B6类、维生素B12类、维生素C类、维生素D类、维生素E类、生物素、泛酸钙、烟酰胺、维生素P及其衍生物等)、氯化甲基甲硫氨酸锍、氨基酸类(抗坏血酸及L-半胱氨酸等)、腺苷三磷酸·2钠盐、酶(淀粉消化酶、蛋白消化酶、脂肪消化酶及纤维素消化酶等)、丙戊酸钠、布洛芬、愈创甘油醚(グアイフエネシン)及溴化丁溴东莨菪碱等,作为产生须晶的药物可以举出布洛芬、无水咖啡因、乙基水杨酰胺、异丙安替比林及L-薄荷脑等。这些药物的配合量可以根据药物的用途适当调整,相对于芯材优选为0.1~99重量%、更优选为1~85重量%。In the present invention, the drug contained in the core material is a drug whose safety for oral administration has been confirmed, and is not particularly limited as long as it is suitable for sugar-coated preparations. Whisker drugs, etc. For example, drugs having an unpleasant smell include herbal medicines (okisoamina powder, hops, barley, herbal medicines, ginseng, astragalus, fennel, cloves, ginger, and belladonna extracts, etc.), garlic processed products, methyl sulfide chloride, etc. Aminosulfonium sulfonium, L-cysteine, vitamin B 1, etc., various vitamins (vitamin A, vitamin B 1 , vitamin B 2 , vitamin B 6, vitamin B 6 , etc.) Vitamin B 12 , vitamin C, vitamin D, vitamin E, biotin, calcium pantothenate, nicotinamide, vitamin P and its derivatives, etc.), sulfonium chloride methylmethionine, amino acids (ascorbic acid and L-cysteine, etc.), adenosine triphosphate·2 sodium salt, enzymes (starch-digesting enzyme, protein-digesting enzyme, fat-digesting enzyme, cellulose-digesting enzyme, etc.), sodium valproate, ibuprofen, guaiac Examples of whisker-generating drugs include glyceryl ether (Gaifinesin) and scopolamine bromide, ibuprofen, anhydrous caffeine, ethyl salicylamide, iprofen, and L-menthol. The compounding quantity of these drugs can be adjusted suitably according to the use of a drug, Preferably it is 0.1-99 weight% with respect to a core material, More preferably, it is 1-85 weight%.

本发明中,作为芯材所含的药物,例如优选举出以下的药物。In the present invention, examples of the drug contained in the core material preferably include the following drugs.

〔大蒜加工物〕〔Garlic processed product〕

大蒜加工物是加工处理百合科葱属大蒜(Allium sativum l.)的鳞茎而获得的。加工处理的方法并无特别限定,例如可以举出将生大蒜干燥后进行粉末化得到的;利用水蒸汽蒸馏、油、水、热水或水溶性有机溶剂等提取生大蒜而得到的;利用加热等处理生大蒜得到的。作为提取所使用的油,可以举出菜籽油、橄榄油、大豆油等食用植物油,水溶性有机溶剂可以举出乙醇、异丙醇等低级醇;丙二醇、二甘醇等二醇等。大蒜加工物特别优选干燥后粉末化得到的、用低级醇提取得到的、进行了加热的加工处理得到的。另外,大蒜加工物还可以是市售品。例如优选加工大蒜、大蒜提取液、大蒜浸膏、干燥大蒜等,特别优选加工大蒜。这里,加工大蒜为干燥利用低级醇提取加热处理大蒜而获得的提取液的大蒜粉末,例如市售有オキソアミヂン(注册商标)(理研化学工业(株)制)及オキソレヂン(注册商标)(理研化学工业(株)制)。大蒜浸膏例如市售有大蒜浸膏(アルプス药品工业(株))、大蒜流浸膏(日本粉末药品(株))等。干燥大蒜例如市售有ガ一リツクパウダ一、ロ一ストガ一リツクパウダ一EX(理研化学工业(株)制)。这些市售的大蒜加工物中,优选オキソアミヂン(注册商标)(理研化学工业(株)制)、オキソレヂン(注册商标)(理研化学工业(株)制)、大蒜浸膏(アルプス药品工业(株))、大蒜流浸膏(日本粉末药品(株))。大蒜加工物的配合量可以根据糖衣制剂的用途适当调整,相对于芯材优选为2~30重量%、更优选为5~15重量%。Garlic processed products are obtained by processing the bulbs of Allium sativum l. in the family Liliaceae. The method of processing is not particularly limited, and examples include drying raw garlic and then pulverizing it; extracting raw garlic with steam distillation, oil, water, hot water, or a water-soluble organic solvent; And so on to get raw garlic. The oil used for extraction includes edible vegetable oils such as rapeseed oil, olive oil, and soybean oil, and the water-soluble organic solvent includes lower alcohols such as ethanol and isopropanol; glycols such as propylene glycol and diethylene glycol; and the like. The garlic processed product is particularly preferably dried, powdered, extracted with a lower alcohol, or processed with heat. In addition, a processed garlic product may be a commercially available product. For example, processed garlic, garlic extract, garlic extract, dried garlic, etc. are preferable, and processed garlic is particularly preferable. Here, processed garlic is garlic powder obtained by drying an extract obtained by heat-treating garlic by extraction with a lower alcohol. (strain) system). Garlic extracts are commercially available, for example, garlic extracts (Alps Pharmaceutical Co., Ltd.), garlic liquid extracts (Nippon Powder Pharmaceutical Co., Ltd.), and the like. Dried garlic is commercially available, for example, Garlic Pounder and Rosette Garlic Pounder EX (manufactured by Riken Chemical Industry Co., Ltd.). Among these commercially available garlic processed products, Okisoramin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.), Okisoramin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.), garlic extract (Alps Pharmaceutical Industry Co., Ltd.) are preferable. ), garlic liquid extract (Japan Powder Pharmaceutical Co., Ltd.). The compounding quantity of the garlic processed product can be adjusted suitably according to the use of a sugar-coated preparation, Preferably it is 2-30 weight% with respect to a core material, More preferably, it is 5-15 weight%.

〔氯化甲基甲硫氨酸锍〕〔Sulfonium methylmethionine chloride〕

氯化甲基甲硫氨酸锍(MMSC)可以根据公知的制造方法获得。另外,市售品例如市售有氯化甲基甲硫氨酸锍(米泽浜理药品制、アルプス药品工业制)等。MMSC的配合量相对于芯材优选为1~80重量%、更优选为10~40重量%。Methylmethioninesulfonium chloride (MMSC) can be obtained by a known production method. In addition, commercially available products include, for example, methyl methionine sulfonium chloride (manufactured by Yonezawahama Riyaku Co., Ltd., manufactured by Alps Pharmaceutical Co., Ltd.). The blending amount of MMSC is preferably 1 to 80% by weight, more preferably 10 to 40% by weight, based on the core material.

另外,配合MMSC的芯材中还优选含有中和胃酸的成分或抑制胃酸分泌的成分(制酸成分)、提高胃动力的成分(健胃成分)、辅助消化的成分(消化酶)、修复胃粘膜的成分(粘膜修复成分)等。In addition, the core material containing MMSC also preferably contains ingredients that neutralize gastric acid or inhibit gastric acid secretion (antacid ingredients), ingredients that improve gastric motility (stomach-enhancing ingredients), ingredients that aid digestion (digestive enzymes), repair stomach Components of mucous membranes (mucosal repair components), etc.

制酸成分可以举出合成铝碳酸镁、碳酸氢钠、铝镁硅酸盐、氢氧化铝.碳酸氢钠共沉淀物、颠茄浸膏、氢氧化铝、碳酸氢钠、碳酸镁、沉降碳酸钙、沉降碳酸镁、二羟基氨基乙酸铝、氢氧化镁、氧化镁、干燥氢氧化铝凝胶、硅酸铝酸镁铋、硅酸镁、合成硅酸钙、盐酸雷尼替丁、西咪替丁、法莫替丁、尼扎替丁、拉呋替丁、奥美拉唑、兰素拉唑、泮托拉唑、雷贝拉唑钠、来明拉唑、埃索美拉唑、盐酸哌仑西平、丙谷胺等。The acid-making components can include synthetic aluminum magnesium carbonate, sodium bicarbonate, aluminum magnesium silicate, aluminum hydroxide, sodium bicarbonate coprecipitate, belladonna extract, aluminum hydroxide, sodium bicarbonate, magnesium carbonate, sedimentation carbonic acid Calcium, Precipitated Magnesium Carbonate, Aluminum Dihydroxy Glycinate, Magnesium Hydroxide, Magnesium Oxide, Dry Aluminum Hydroxide Gel, Magnesium Bismuth Aluminosilicate, Magnesium Silicate, Synthetic Calcium Silicate, Ranitidine Hydrochloride, Cimet Tidine, famotidine, nizatidine, lafutidine, omeprazole, lansoprazole, pantoprazole, rabeprazole sodium, leminoprazole, esomeprazole, Pirenzepine hydrochloride, proglumide, etc.

健胃成分可以举出当药末、啤酒花浸膏、龙胆(ゲンチアナ)浸膏、茴香末、生姜末、丁香末、野桐(アカメガシワ)末、儿茶钩藤(アセンヤク)末、郁金末、乌梅末、乌药末、黄芩末、黄柏末、黄连末、莪术末、杜鹃(カツコウ)末、甘草末、积壳(キコク)末、金鸡纳末、苦参末、桂皮末、决明子末、老鹳草(ゲンノショウコ)末、红参末、厚朴末、吴茱萸末、五倍子末、コロンボ末、陈皮末、山楂末、山椒末、草果药(サンナ)末、紫苏子末、姜花(シユクシヤ)末、小豆蔻(ショウズク)末、青皮(セイヒ)末、石菖蒲(セキショウコン)末、苍术末、紫苏(ソョウ)末、大黄末、竹节参(チクセツニンジン)末、桧树(トウヒ)末、苦树(ニガキ)末、肉豆蔻(ニクズク)末、人参末、毛叶香茶菜(ヒキオコシ)末、荜拨(ヒハツ)末、白术(ビヤクジユツ)末、木香末、益智末、杨梅皮末、薄荷油、龙胆(リンドウ)末、高良姜(リョウキョウ)末、茴香籽、芦荟、睡菜叶(スイサイョウ)、大茴香(ダイウイキョウ)、牛奶藤(コンズランゴ)、加工大蒜、菖蒲根(カラムス根)、百金花草(センタウリウム草)、马钱子(ホミカ)浸膏、干燥酵母、肉碱氯化物、谷氨酸、氯贝胆碱(塩化ベタネコ一ル)、马来酸曲美布汀(マレイン酸トリメブチン)等。Stomach invigorating ingredients include powdered medicine, hops extract, gentian (Gentiana) extract, fennel powder, ginger powder, clove powder, wild tung (Akamegashiwa) powder, catechu powder , ebony powder, black medicine powder, scutellaria baicalensis powder, phellodendron powder, coptis powder, zedoary powder, rhododendron (カツコウ) powder, licorice powder, husk (キコク) powder, cinchona powder, flavescens powder, cinnamon powder, cassia seed powder, Geranium (ゲンノショウウコ) powder, red ginseng powder, Magnolia officinalis powder, Evodia fruit powder, Chinese gallnut powder, Coronbo powder, tangerine peel powder, hawthorn powder powder, Sanjiao powder, herbal medicine (Sanna) powder, perilla seed powder, ginger flower (シュクシヤ) powder, cardamom powder, seihi powder powder, stone calamus powder powder, atractylodes powder powder, perilla powder powder, rhubarb powder powder, bamboo ginseng powder powder, juniper tree powder (ヒウヒ) powder, bitter tree (Nigaki) powder, nutmeg (Nikuzuku) powder, ginseng powder, hairy leaf fragrant tea (ヒキオコシ) powder, Piper dial (Hヒハツ) powder, Atractylodes macrocephala (Biyaku ジュツ) powder, woody powder, benefit Chi powder, bayberry peel powder, peppermint oil, gentian powder, galangal powder, fennel seed, aloe vera, suisai leaf, aniseed fennel, milk vine, Processed Garlic, Calamus Root (Karamus Root), Centauria (Centauria), Nuxychia (Homika) Extract, Dried Yeast, Carnitine Chloride, Glutamic Acid, Bectoline (塩化ベタネコル), trimebutine maleate (trimebutine maleate) and the like.

消化酶可以举出米曲霉(ビオヂアスタ一ゼ)、脂肪酶、熊去氧胆酸、含糖人胃蛋白酶、ジアスメン、纤维素酶、セルロシン、高峰氏淀粉酶(タカヂアスタ一ゼ)、胆汁末、デヒドロコ一ル、新脂肪酶(ニユ一ラ一ゼ)、胰酶、蛋白质水解酶(ビオタミラ一ゼ)、蛋白水解酶(プロザイム)、ポリパ一ゼ等。Examples of digestive enzymes include Aspergillus oryzae, lipase, ursodeoxycholic acid, sugar-containing human pepsin, jasmen, cellulase, celrosin, Takasa amylase, bile powder, dehidroko Il, new lipase (Niyu-la-ze), pancreatin, proteolytic enzyme (Biotamira-ze), proteolytic enzyme (Prozaim), Polyperase, etc.

粘膜修复成分可以举出硫糖铝(スクラルフア一ト)、尿囊素铝(アルジオキサ)、L-谷氨酰胺、索法酮(ソフアルコン)、叶绿素铜钠(銅クロロフインナトリウム)、叶绿素铜钾(銅クロロフインカリウム)、盐酸西曲酸酯(塩酸セトラキサ一ト)、吉法酯(ゲフアルナ一ト)、马来酸曲美布汀片、甘菊蓝磺酸钠(アズレンスルフオン酸ナトリウム)等。The mucosal repairing components include sucralfate (scrallfate), aluminum allantoin (Algiokisa), L-glutamine, sofalcone (Sofarcon), sodium copper chlorophyllin (copper chlorophyllinatrium), potassium copper chlorophyllin ( Copper Chrolfinkarium), Cetraxate Hydrochloride (Setrakisate Hydrochloride), Gefarate (Gefalnat), Trimebutine Maleate Tablets, Sodium Azulene Sulfonate .

〔丙戊酸钠〕〔Sodium valproate〕

丙戊酸钠可以根据公知的制造方法获得(例如参照特开昭60-156638号公报、特开昭62-106041号公报、特开昭63-122646号公报、特开平10-130197号公报)。另外,市售品例如市售有丙戊酸钠(日本合成化学工业制、アリババ制)等。丙戊酸钠的配合量相对于芯材优选为1~80重量%、更优选为30~60重量%。Sodium valproate can be obtained by known production methods (for example, refer to JP-A-60-156638, JP-A-62-106041, JP-A-63-122646, JP-10-130197). Moreover, as a commercial item, sodium valproate (manufactured by Nippon Synthetic Chemical Industry Co., Ltd., manufactured by Alibaba) etc. are commercially available, for example. The compounding quantity of sodium valproate is preferably 1-80 weight% with respect to a core material, More preferably, it is 30-60 weight%.

另外,芯材中除了上述药物之外,还可以根据需要配合可口服给药的各种任意成分。作为这种可口服给药的各种任意添加物例如可以举出赋形剂、粘合剂、崩解剂、光滑剂等。In addition, in addition to the above-mentioned drugs, various optional components that can be administered orally can be added to the core material as needed. Examples of various optional additives that can be administered orally include excipients, binders, disintegrants, lubricants and the like.

赋形剂可以举出乳糖、结晶纤维素、蔗糖、甘露醇、轻质硅酸酐、磷酸氢钙及玉米淀粉等。Examples of excipients include lactose, crystalline cellulose, sucrose, mannitol, light anhydride silicic acid, calcium hydrogen phosphate, and corn starch.

粘合剂可以举出甲基纤维素、羟丙基纤维素、羟丙基甲基纤维素、明胶、聚乙烯吡咯烷酮及支链淀粉等。Examples of the binder include methylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, gelatin, polyvinylpyrrolidone, and pullulan.

崩解剂可以举出羧甲纤维素钙、低取代度羟丙基纤维素、交联聚维酮及交联羧甲纤维素钠等。Examples of the disintegrant include carmellose calcium, low-substituted hydroxypropyl cellulose, crospovidone, and croscarmellose sodium.

光滑剂可以举出硬脂酸镁、硬脂酸钙及滑石粉等。Examples of lubricants include magnesium stearate, calcium stearate, and talc.

本发明糖衣制剂所使用的芯材可以使用药物及其他任意成分根据常规方法制造。The core material used in the sugar-coated preparation of the present invention can be produced by a conventional method using drugs and other optional ingredients.

例如,为素片时,在对配合的药物及其他任意添加物进行制粒后对制粒物进行压片的方法;或者对配合的药物及其他任意添加物进行制粒后利用整粒机对它们进行整粒制成粉体,进而根据需要在该粉体中添加其他任意添加物制成混合的粉体后,对这些粉体进行压片的方法;或者混合直接配合的药物及其他任意添加物使用压片机进行压片的方法等。For example, when it is a plain tablet, the method of compressing the granulated product after granulating the compounded drug and other optional additives; or using a granulator to granulate the compounded drug and other optional additives They are granulated to make powder, and then according to the need, add other arbitrary additives to the powder to make a mixed powder, and then compress these powders; or mix directly compounded drugs and other arbitrary additives A method for compressing a substance into tablets using a tablet press, etc.

这里,制粒可以举出干式制粒法和湿式制粒法,干式制粒法是指不使用水、乙醇、异丙醇及它们的混合液等液体利用干式制粒机等将粉体压缩成形,制成板状的固态物后将它们破坏,制制粒状物的方法。Here, granulation can include dry granulation method and wet granulation method, and dry granulation method means that powder is granulated by dry granulator without using liquids such as water, ethanol, isopropanol, and their mixtures. The body is compressed and formed, and then the plate-shaped solids are crushed to produce granular objects.

另外,湿式制粒法是指使用高速搅拌制粒机、混炼制粒机、流化床制粒机、转动流动制粒机等将粘合液添加于粉体中,形成粒子后实施干燥的方法,粘合液的种类并无特别限定,可以使用水、乙醇、异丙醇及它们的混合液。In addition, the wet granulation method refers to the process of adding a binding liquid to the powder by using a high-speed stirring granulator, a mixing granulator, a fluidized bed granulator, a rotary flow granulator, etc., forming particles and then drying them. As a method, the type of adhesive liquid is not particularly limited, and water, ethanol, isopropanol, and a mixture thereof can be used.

接着,为芯颗粒时,可以举出使用干式制粒法将配合的药物及其他任意添加物颗粒化的方法、组合湿式制粒法或湿式制粒法和挤出制粒法进行颗粒化的方法等。Next, in the case of core granules, a method of granulating the compounded drug and other optional additives using a dry granulation method, a method of granulating a wet granulation method or a combination of a wet granulation method and an extrusion granulation method method etc.

包覆本发明糖衣制剂所含上述芯材的糖衣层的至少1层的特征在于含有糖及丙烯酸乙酯/甲基丙烯酸甲酯共聚物0.01~10重量%。At least one layer of the sugar coating layer covering the core material contained in the sugar coating preparation of the present invention contains 0.01 to 10% by weight of sugar and ethyl acrylate/methyl methacrylate copolymer.

另外,本发明的糖衣制剂除了使用本发明糖衣液形成的1层或多层糖衣层之外,还可以具有由其他包衣液形成的1层或多层包覆层。予以说明,本说明书中,将使用本发明的糖衣液形成的层记载为“糖衣层”、将该糖衣层及使用本发明糖衣液以外的包衣液形成的层一并记载为“包覆层”。In addition, the sugar-coated preparation of the present invention may have one or more coating layers formed of other coating liquids in addition to the one or more sugar-coating layers formed using the sugar-coating liquid of the present invention. Note that, in this specification, the layer formed using the sugar-coating solution of the present invention is described as a "sugar-coating layer", and the sugar-coating layer and layers formed using a coating solution other than the sugar-coating solution of the present invention are collectively described as a "coating layer". ".

包覆层可以根据其功能分为防水层(保护层,protective coating)、底涂层(subcoating)、中涂层(smoothing)、上涂层(coloring)及抛光层(polishing)等多个层等。这些各层相对于包覆层整体的比例通常防水层为0~20%、底涂层为15~100%、中涂层为0~50%、上涂层为0~50%及抛光层为0~10%。防水层为用于防止糖衣工序中水分向芯材的移动而实施。另外,底涂层为用于规整糖衣片外形而实施,该底涂层的好坏会影响到糖衣片的外观、强度的好坏。另外,中涂层为用于平滑糖衣片表面而实施、上涂层为着色用于提高糖衣片的识别性或商品价值而实施、抛光层为用于赋予糖衣片光泽而实施。本发明的糖衣制剂没有必要具有具备上述功能的全部包覆层,优选含有具有底涂层功能的包覆层,使用本发明糖衣液形成的糖衣层可以作为具有底涂层功能的包覆层优选使用。The cladding layer can be divided into multiple layers such as waterproof layer (protective coating), subcoating, smoothing, coloring and polishing according to its function. . The ratio of these layers to the overall coating layer is usually 0-20% for the waterproof layer, 15-100% for the primer layer, 0-50% for the middle coat layer, 0-50% for the top coat layer, and 0-50% for the polishing layer. 0-10%. The waterproof layer is implemented to prevent migration of moisture to the core material during the sugar coating process. In addition, the undercoat is applied to regulate the shape of the sugar-coated tablet, and the quality of the undercoat affects the appearance and strength of the sugar-coated tablet. In addition, the middle coat is applied to smooth the surface of sugar-coated tablets, the top coat is applied to color the sugar-coated tablets to improve the visibility and commercial value, and the polishing layer is applied to impart luster to the sugar-coated tablets. The sugar-coated preparation of the present invention does not necessarily have all the coating layers with the above-mentioned functions, and preferably contains a coating layer with a primer function. The sugar-coat layer formed by using the sugar-coating liquid of the present invention can be used as a coating layer with a primer function. use.

而且,本发明的糖衣制剂中还可以根据目的与上述包覆层不同地包覆控释层。控释层为用于赋予控制芯材所含药物溶出的功能而实施的,可以为1层或多层。控释层可以直接包覆在芯材上,或者还可以在上述防水层、底涂层、中涂层、上涂层及抛光层的任何之间实施,通常优选包覆在芯材上。包覆控释层时,相对于糖衣制剂1重量部优选为1~10重量%、更优选为2~8重量%。另外,实施控释层的方法或所用的成分可以使用常规方法或成分。Furthermore, the sugar-coated preparation of the present invention may be coated with a controlled-release layer differently from the above-mentioned coating layer according to the purpose. The controlled-release layer is implemented to impart a function of controlling the dissolution of the drug contained in the core material, and may be one or more layers. The controlled-release layer can be directly coated on the core material, or can also be implemented between any of the above-mentioned waterproof layer, primer coat, middle coat, top coat and polishing layer, and is usually preferably coated on the core material. When coating the controlled-release layer, it is preferably 1 to 10% by weight, more preferably 2 to 8% by weight, based on 1 weight part of the sugar-coated preparation. In addition, conventional methods and components can be used for the method of implementing the controlled release layer or the components used.

本发明糖衣制剂的使用本发明糖衣液形成的糖衣层的重量相对于芯材的重量优选为5~60重量%、更优选为10~50重量%。当糖衣层的重量超过60重量%时,包衣工序的时间延长,相对于装入的芯材的质量,得到的糖衣制剂的质量增大,因此产生另外需要包衣装置的问题。另外,小于5重量%时,无法获得充分的包覆层硬度,另外,由于包覆层很薄,因此具有难以从环境湿度中保护素片或芯颗粒等内容物等的问题。In the sugar-coated preparation of the present invention, the weight of the sugar-coated layer formed using the sugar-coated solution of the present invention is preferably 5 to 60% by weight, more preferably 10 to 50% by weight, based on the weight of the core material. When the weight of the sugar-coat layer exceeds 60% by weight, the time of the coating process will be prolonged, and the mass of the obtained sugar-coated preparation will increase relative to the mass of the core material to be charged, thus causing a problem that a coating device is required separately. In addition, if it is less than 5% by weight, sufficient hardness of the coating layer cannot be obtained, and since the coating layer is thin, there is a problem that it is difficult to protect the contents such as the plain sheet and core particles from the ambient humidity.

本发明糖衣制剂的吸湿率在温湿度25℃-85%的24小时后的条件下优选为1.0%以下、更优选为0.5%以下,在温湿度40℃-75%的30日后的条件下优选为4.0%以下、更优选为3.0%以下。另外,对于硬度或崩解度而言,可以根据本发明糖衣制剂的使用目的或芯材所含药物适当调整。The moisture absorption rate of the sugar-coated preparation of the present invention is preferably 1.0% or less, more preferably 0.5% or less under the condition of temperature and humidity of 25°C-85% after 24 hours, and preferably under the condition of temperature and humidity of 40°C-75% after 30 days. 4.0% or less, more preferably 3.0% or less. In addition, hardness and disintegration can be appropriately adjusted according to the purpose of use of the sugar-coated preparation of the present invention or the drug contained in the core material.

本发明糖衣制剂的芯材含有大蒜加工物时,糖衣制剂的硬度优选为100N以上、更优选为110N以上。另外,崩解度优选为25分钟以内。When the core material of the sugar-coated preparation of the present invention contains processed garlic, the hardness of the sugar-coated preparation is preferably 100N or higher, more preferably 110N or higher. In addition, the disintegration degree is preferably within 25 minutes.

本发明糖衣制剂的芯材含有MMSC时,糖衣制剂的硬度优选为65N以上、更优选为70N以上。另外,崩解度优选为15分钟以内。When the core material of the sugar-coated preparation of the present invention contains MMSC, the hardness of the sugar-coated preparation is preferably 65N or higher, more preferably 70N or higher. In addition, the disintegration degree is preferably within 15 minutes.

本发明糖衣制剂的芯材含有丙戊酸钠时,糖衣制剂的硬度优选为65N以上、更优选为70N以上。When the core material of the sugar-coated preparation of the present invention contains sodium valproate, the hardness of the sugar-coated preparation is preferably 65N or higher, more preferably 70N or higher.

本发明的糖衣制剂可以通过同时进行本发明糖衣液的喷雾工序及干燥工序的连续包衣法形成糖衣层而制造。即,通过一边将本发明糖衣液喷雾于含有药物的芯材一边进行干燥,可以使包覆芯材的糖衣液中的溶剂挥散,形成糖衣层。另外,还可以利用所用芯材(素片或芯颗粒)制成糖衣片或糖衣颗粒的剂形。The sugar-coated preparation of the present invention can be produced by forming a sugar-coated layer by a continuous coating method in which a spraying step and a drying step of the sugar-coating solution of the present invention are performed simultaneously. That is, by drying the drug-containing core material while spraying the sugar-coating solution of the present invention, the solvent in the sugar-coating solution covering the core material can be volatilized to form a sugar-coated layer. In addition, the dosage form of sugar-coated tablets or sugar-coated granules can also be made by using the core material (plain tablet or core granule).

制造糖衣片时,可以通过在连续旋转的包衣装置内投入含有药物的素片或对其实施了防水层等的保护片,对装置内旋转的素片或保护片同时进行糖衣液的喷雾和干燥形成包覆芯材的糖衣层。作为连续包衣法所用的装置例如可以举出ハイコ一タ一(フロイント产业)、アクアコ一タ一(フロイント产业)、パウレツクコ一タ一(パウレツク)、ドリアコ一タ一(パウレツク)等。When producing sugar-coated tablets, the plain tablet containing the drug or the protective sheet with a waterproof layer or the like can be put into the continuously rotating coating device, and the sugar-coating liquid can be sprayed and sprayed on the plain tablet or protective tablet rotating in the device at the same time. Dries to form a sugar coating that coats the core material. As an apparatus used in the continuous coating method, for example, Hicoater (Floint Industry), Aquacoater (Floint Industry), Powreck Cotter (Pauretsuku), Doriacoater (Powreku) and the like can be mentioned.

喷雾的糖衣液的液滴径优选为0.1~1000μm、喷雾量可以根据芯材的大小或量进行调整使得涉及芯材的整个表面。另外,糖衣液的温度优选为10~80℃。给气温度和风量优选按照制品温度达到10~60℃进行调节。The droplet diameter of the sprayed sugar-coating liquid is preferably 0.1-1000 μm, and the spray amount can be adjusted according to the size or amount of the core material so as to cover the entire surface of the core material. In addition, the temperature of the sugar coating solution is preferably 10 to 80°C. The air supply temperature and air volume are preferably adjusted according to the product temperature reaching 10-60°C.

制造糖衣颗粒时,优选使用流化床包衣机进行,特别优选使用底部具有旋转盘的转动流化床包衣机。例如可以举出マルチプレツクス(パウレツク)、グラニユレツクス(フロイント产业)、スパイラフロ一(フロイント产业)、アグロマスタ(ホソカワミクロン)、ニユ一マルメライザ一(不二パウダル)等。When producing sugar-coated granules, it is preferable to use a fluidized bed coater, and it is particularly preferable to use a rotating fluidized bed coater with a rotating disk at the bottom. For example, Maltipurex (Powrec), Granyurex (Floint Industry), Spiraflow (Floint Industry), Agromaster (Hosokawa Micron), Niyuyi Malmelaser (Fuji Poutal) and the like can be mentioned.

连续地向主体底面部旋转的包衣装置内投入含有药物的颗粒或对其实施了防水层等的带保护颗粒,对装置内流动及旋转的颗粒或带保护颗粒同时进行糖衣液的喷雾和干燥,可以形成包覆芯材的糖衣层。Continuously inject drug-containing granules or protected granules with a water-repellent layer into the coating device that rotates on the bottom of the main body, and simultaneously spray and dry the sugar-coated granules or protected granules that flow and rotate in the device , can form a sugar coating layer covering the core material.

喷雾的糖衣液的液滴径优选为0.1~100μm、喷雾量可以根据芯材的大小或量进行调整使得涉及芯材的整个表面。另外,糖衣液的温度优选为10~80℃。给气温度和风量优选按照制品温度达到10~50℃进行调节。The droplet diameter of the sprayed sugar coating solution is preferably 0.1 to 100 μm, and the spray amount can be adjusted according to the size or amount of the core material so as to cover the entire surface of the core material. In addition, the temperature of the sugar coating solution is preferably 10 to 80°C. The air supply temperature and air volume are preferably adjusted according to the product temperature reaching 10-50°C.

另外,利用本发明糖衣液以外的包衣液的包覆层的形成可以通过制造糖衣制剂时一般使用的方法进行。此时所用的包衣装置也可根据包衣液的种类等适当选择,并无特别限定。另外,对于喷雾包衣液时的液滴或喷雾量而言,也可与糖衣液的喷雾同样地调节。In addition, the formation of the coating layer using a coating solution other than the sugar-coating solution of the present invention can be performed by a method generally used in the production of sugar-coated preparations. The coating device used at this time can also be appropriately selected according to the type of coating liquid, etc., and is not particularly limited. In addition, the liquid droplets or the amount of spray when spraying the coating liquid can also be adjusted in the same manner as the spraying of the sugar-coating liquid.

如此获得的本发明糖衣制剂与以往制剂相比,糖衣层薄、具有充分的硬度、且低吸湿性、防臭性及崩解性也优异。The sugar-coated preparation of the present invention thus obtained has a thinner sugar-coated layer, sufficient hardness, low hygroscopicity, deodorant property, and disintegration property compared with conventional preparations.

实施例Example

以下使用实施例具体地说明本发明。The present invention will be specifically described below using examples.

<制造例1><Manufacturing example 1>

将乳糖3000g、羟丙基纤维素(HPC-L:日本曹达)150g、玉米淀粉1200g、结晶纤维素(セオラスPH-101:旭化成)1000g投入高速搅拌制粒机(VG-25:パウレツク)中,加入精制水调制制粒物。使用流化床干燥机(FLO-5B:フロイント产业)对其干燥,之后使用整粒机(パワ一ミル、昭和化学机械)对干燥物整粒。Put 3,000 g of lactose, 150 g of hydroxypropyl cellulose (HPC-L: Nippon Soda), 1,200 g of corn starch, and 1,000 g of crystalline cellulose (Seolas PH-101: Asahi Kasei) into a high-speed stirring granulator (VG-25: Powrec) , adding purified water to prepare granules. This was dried using a fluidized bed dryer (FLO-5B: FLOINT INDUSTRY), and then the dried product was sized using a granulator (Power Mill, Showa Chemical Machinery).

向所得整粒物5350g混合硬脂酸镁50g,使用旋转式压片机(HP-AP18-SS:

Figure G2007800281535D00111
鐵工所)将其制成每1片为270mg的素片。50 g of magnesium stearate was mixed with 5350 g of the obtained granules, and a rotary tablet machine (HP-AP18-SS:
Figure G2007800281535D00111
Iron Works) made it into plain tablets of 270 mg per tablet.

对所得素片5400g,使用含有羟丙基甲基纤维素2910(TC-5R:信越化学工业)100g及精制水900g的包衣液、利用包衣机(ドリアコ一タ一DRC-650、パウレツク)对素片实施防水层,制造每1片为275mg的保护片。To 5400 g of the obtained plain tablets, a coating solution containing 100 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Industry) and 900 g of purified water was used, and a coating machine (Driacoater DRC-650, Powrec) was used. A water-repellent layer was applied to the plain sheet to produce a protective sheet of 275 mg per tablet.

<实施例1><Example 1>

对制造例1获得的保护片5500g,使用含有砂糖1180g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)66.7g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。予以说明,包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 1, 66.7 g and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoat DRC-650, Powrec) while drying the sugar-coated liquid to obtain 375 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 2 hours.

<实施例2><Example 2>

对制造例1获得的保护片5500g,使用含有砂糖1160g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)133.3g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 1, 133.3 g and The sugar-coated solution suspended in 2,000 g of purified water was sprayed with a coating machine (Driacoat DRC-650, Pautsuku) while drying the sugar-coated solution to obtain 375 mg sugar-coated tablets per tablet. The time taken for the coating work was 2 hours.

<实施例3><Example 3>

对制造例1获得的保护片5500g,使用含有砂糖1120g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)266.7g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 1, 266.7 g and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoat DRC-650, Powrec) while drying the sugar-coated liquid to obtain 375 mg sugar-coated tablets per tablet. The time taken for the coating work was 2 hours.

<比较例1><Comparative example 1>

对制造例1获得的保护片5500g,使用含有砂糖1160g、滑石粉400g、沉降碳酸钙400g、羟丙基甲基纤维素2910(TC-5R:信越化学工业)40g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 1, a suspension containing 1160 g of granulated sugar, 400 g of talc powder, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Industry) and 2000 g of purified water was used. The sugar-coated solution was sprayed with a coating machine (Driacoater DRC-650, Powrec) while drying, to obtain 375 mg sugar-coated tablets per tablet. The time taken for the coating work was 2 hours.

<比较例2><Comparative example 2>

对制造例1获得的保护片5500g,使用含有砂糖1924g、滑石粉542g、沉降碳酸钙818g、阿拉伯胶64g、明胶30g、聚氧乙烯(105)聚氧丙烯(5)二醇(PEP-101:フロイント产业)22g及精制水1200g的混悬的糖衣液,利用使用包衣机(ドリアコ一タ一DRC-650、パウレツク)分别进行糖衣液喷雾、蒸发、干燥的现有糖衣包衣方法,获得每1片为445mg的糖衣片。包衣作业所消耗的时间为6.5小时。For 5500 g of the protective sheet obtained in Manufacturing Example 1, use was made of 1924 g of granulated sugar, 542 g of talc, 818 g of precipitated calcium carbonate, 64 g of gum arabic, 30 g of gelatin, polyoxyethylene (105) polyoxypropylene (5) diol (PEP-101: FLOINT INDUSTRIAL) 22g and purified water 1200g of the suspension sugar-coating liquid, utilize the existing sugar-coating coating method of spraying, evaporating, and drying the sugar-coating liquid using a coating machine (Driacota-DRC-650, Powrec), respectively, to obtain each 1 sugar-coated tablet of 445 mg. The time taken for the coating operation was 6.5 hours.

<制造例2><Manufacturing example 2>

将大蒜加工物500g(オキソアミヂン、理研化学工业(株)制)、乳糖2500g、羟丙基纤维素(HPC-L:日本曹达)150g、玉米淀粉1200g、结晶纤维素(セオラスPH-101:旭化成)1000g投入高速搅拌制粒机(VG-25:パウレツク),加入精制水,调制制粒物。使用流化床干燥机(FLO-5B:フロイント产业)对其干燥,之后使用整粒机(パワ一ミル、昭和化学机械)对干燥物进行整粒。Garlic processed product 500g (Okiso Amino, manufactured by Riken Chemical Industry Co., Ltd.), lactose 2500g, hydroxypropyl cellulose (HPC-L: Nippon Soda) 150g, cornstarch 1200g, crystalline cellulose (Seoras PH-101: Asahi Kasei ) 1000 g was put into a high-speed stirring granulator (VG-25: Powrec), and purified water was added to prepare a granulated product. This was dried using a fluidized bed dryer (FLO-5B: FLOINT INDUSTRY), and then the dried product was sized using a granulator (Powa Mill, Showa Chemical Machinery).

向所得整粒物5350g混合硬脂酸镁50g,使用旋转式压片机(HP-AP18-SS:

Figure G2007800281535D00131
鐵工所)将其制造每1片为270mg的素片。50 g of magnesium stearate was mixed with 5350 g of the obtained granules, and a rotary tablet machine (HP-AP18-SS:
Figure G2007800281535D00131
Iron Works) to manufacture plain tablets of 270 mg per tablet.

对所得素片5400g,使用含有羟丙基甲基纤维素2910(TC-5R:信越化学工业)100g及精制水900g的包衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)对素片实施防水层,制造每1片为275mg的保护片。5400 g of the obtained plain tablets were coated with a coating solution containing 100 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Industry) and 900 g of purified water, and a coating machine (Driacoater DRC-650, Powrec) was used. A water-repellent layer was applied to the plain sheet to produce a protective sheet of 275 mg per tablet.

<实施例4><Example 4>

对制造例2获得的保护片5500g,使用含有砂糖1180g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)66.7g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。予以说明,包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 2, 66.7 g and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoat DRC-650, Powrec) while drying the sugar-coated liquid to obtain 375 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 2 hours.

<实施例5><Example 5>

对制造例2获得的保护片5500g,使用含有砂糖1160g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)133.3g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。予以说明,包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 2, 133.3 g and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoat DRC-650, Powrec) while drying the sugar-coated liquid to obtain 375 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 2 hours.

<实施例6><Example 6>

对制造例2获得的保护片5500g,使用含有砂糖1120g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)266.7g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。予以说明,包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 2, 266.7 g and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoat DRC-650, Powrec) while drying the sugar-coated liquid to obtain 375 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 2 hours.

<比较例3><Comparative example 3>

对制造例2获得的保护片5500g,使用含有砂糖1160g、滑石粉400g、沉降碳酸钙400g、羟丙基甲基纤维素2910(TC-5R:信越化学工业)40g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为375mg的糖衣片。予以说明,包衣作业所消耗的时间为2小时。For 5500 g of the protective sheet obtained in Production Example 2, a suspension containing 1160 g of granulated sugar, 400 g of talc powder, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Industry) and 2000 g of purified water was used. The sugar-coated solution was sprayed with a coating machine (Driacoater DRC-650, Powrec) while drying, to obtain 375 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 2 hours.

<比较例4><Comparative example 4>

对制造例2获得的保护片5500g,使用含有砂糖1924g、滑石粉542g、沉降碳酸钙818g、阿拉伯胶64g、明胶30g、聚氧乙烯(105)聚氧丙烯(5)二醇(PEP-101:フロイント产业)22g及精制水1200g的混悬的糖衣液,利用使用包衣机(ドリアコ一タ一DRC-650、パウレツク)分别进行糖衣液喷雾、蒸发、干燥的现有糖衣包衣方法,获得每1片为445mg的糖衣片。予以说明,包衣作业所消耗的时间为6.5小时。For 5500 g of the protective sheet obtained in Manufacturing Example 2, use 1924 g of granulated sugar, 542 g of talc, 818 g of precipitated calcium carbonate, 64 g of gum arabic, 30 g of gelatin, polyoxyethylene (105) polyoxypropylene (5) diol (PEP-101: FLOINT INDUSTRIAL) 22g and purified water 1200g of the suspension sugar-coating liquid, utilize the existing sugar-coating coating method of spraying, evaporating, and drying the sugar-coating liquid using a coating machine (Driacota-DRC-650, Powrec), respectively, to obtain each 1 sugar-coated tablet of 445 mg. It should be noted that the time taken for the coating work was 6.5 hours.

<制造例3><Manufacturing example 3>

将氯化甲基甲硫氨酸锍1000g(氯化甲基甲硫氨酸锍、米泽浜理药品)、乳糖600g、聚乙烯吡咯烷酮(コリドン30:BASFジヤパン)300g、玉米淀粉1550g、羧甲纤维素钙(ECG-505:五德药品)500g投入到高速搅拌制粒机(VG-25:パウレツク),加入乙醇,调制制粒物。利用流化床干燥机(FLO-5B:フロイント产业)对其干燥,之后利用整粒机(パワ一ミル、昭和化学机械)对干燥物进行整粒。Mix 1000 g of sulfonium chloride methylmethionine (sulfonium chloride methylmethionine, Yonezawa Hamari Pharmaceutical Co., Ltd.), 600 g of lactose, 300 g of polyvinylpyrrolidone (Coridon 30: BASF Japanpan), 1550 g of cornstarch, carboxymethyl 500 g of cellulose calcium (ECG-505: Gotoku Pharmaceutical) was put into a high-speed stirring granulator (VG-25: Powrec), and ethanol was added to prepare a granulated product. This was dried with a fluidized bed dryer (FLO-5B: FLOINT INDUSTRY), and then the dried product was sized with a granulator (Power Mill, Showa Chemical Machinery).

向所得整粒物3950g混合硬脂酸镁50g,利用旋转式压片机(HP-AP18-SS:

Figure G2007800281535D00141
鐵工所)将其制造为每1片为100mg的素片。50 g of magnesium stearate was mixed with 3950 g of the obtained granules, and a rotary tablet press (HP-AP18-SS:
Figure G2007800281535D00141
Iron Works) manufactures it as a plain tablet of 100 mg per tablet.

对所得素片4000g,使用在乙醇600mL中溶解有氢化油400g、单硬脂酸甘油酯(ニツコ一ルMGS-B:日光ケミカル)100g及聚乙二醇单硬脂酸酯(40EO)(ニツコ一ルMYS-40:日光ケミカル)100g的液体和滑石粉200g,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)对素片实施防水层,制造每1片为120mg的保护片。For 4000 g of the obtained plain tablet, 400 g of hydrogenated oil, 100 g of glyceryl monostearate (Nichiko MGS-B: Nikko Chemical) and polyethylene glycol monostearate (40EO) (Nichiko Il MYS-40: Nikko Chemical) 100 g of liquid and talc powder 200 g, and a coating machine (Driacoat DRC-650, Powrec) was used to apply a water-repellent layer to the plain tablet to produce a protective sheet of 120 mg per tablet.

<实施例7><Example 7>

对制造例3获得的保护片4800g,使用含有砂糖1180g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)66.7g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为170mg的糖衣片。予以说明,包衣作业所消耗的时间为1小时。For 4800 g of the protective sheet obtained in Production Example 3, 66.7 g and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoater DRC-650, Powrec) while drying the sugar-coated liquid to obtain 170 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 1 hour.

<实施例8><Embodiment 8>

对制造例3获得的保护片4800g,使用含有砂糖1160g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)133.3g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为170mg的糖衣片。予以说明,包衣作业所消耗的时间为1小时。For 4800 g of the protective sheet obtained in Production Example 3, 133.3 g of a dispersion containing 1160 g of granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and a 30% dispersion of ethyl acrylate/methyl methacrylate copolymer (オイドラギツト NE30D: Hiro Shokai) and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoater DRC-650, Powrec) while drying the sugar-coated liquid to obtain 170 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 1 hour.

<实施例9><Example 9>

对制造例3获得的保护片4800g,使用含有砂糖1120g、滑石粉400g、沉降碳酸钙400g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)266.7g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为170mg的糖衣片。予以说明,包衣作业所消耗的时间为1小时。For 4800 g of the protective sheet obtained in Production Example 3, 266.7 g and The sugar-coated liquid suspended in 2000 g of purified water was sprayed with a coating machine (Driacoater DRC-650, Powrec) while drying the sugar-coated liquid to obtain 170 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 1 hour.

<比较例5><Comparative example 5>

对制造例3获得的保护片4800g,使用含有砂糖1160g、滑石粉400g、沉降碳酸钙400g、羟丙基甲基纤维素2910(TC-5R:信越化学工业)40g及精制水2000g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为170mg的糖衣片。予以说明,包衣作业所消耗的时间为1小时。For 4800 g of the protective sheet obtained in Production Example 3, a suspension containing 1160 g of granulated sugar, 400 g of talc powder, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Industry) and 2000 g of purified water was used. The sugar-coated solution was sprayed with a coating machine (Driacoater DRC-650, Powrec) while drying to obtain 170 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 1 hour.

<比较例6><Comparative example 6>

对制造例3获得的保护片4800g,使用含有砂糖660g、滑石粉1100g、沉降碳酸钙1100g、阿拉伯胶280g、明胶60g及精制水600g的混悬的糖衣液,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)喷雾糖衣液、同时进行干燥,获得每1片为200mg的糖衣片。予以说明,包衣作业所消耗的时间为3.5小时。For 4800 g of the protective sheet obtained in Manufacturing Example 3, using a suspension sugar-coating solution containing 660 g of granulated sugar, 1100 g of talcum powder, 1100 g of precipitated calcium carbonate, 280 g of gum arabic, 60 g of gelatin, and 600 g of purified water, a coating machine (Dria Coater) was used. DRC-650, パュレツク) was sprayed with a sugar-coated solution while drying to obtain 200 mg sugar-coated tablets per tablet. It should be noted that the time taken for the coating work was 3.5 hours.

<制造例4><Manufacturing example 4>

将丙戊酸钠3300g、轻质硅酸酐165g及乙基纤维素303.6g投入高速搅拌制粒机(VG-25:パウレツク),加入乙醇调制制粒物。利用流化床干燥机(FLO-5B:フロイント产业)对其干燥,之后利用整粒机(パワ一ミル、昭和化学机械)对干燥物进行整粒。3300 g of sodium valproate, 165 g of light silicic anhydride, and 303.6 g of ethyl cellulose were put into a high-speed stirring granulator (VG-25: Powrec), and ethanol was added to prepare a granulated product. This was dried with a fluidized bed dryer (FLO-5B: FLOINT INDUSTRY), and then the dried product was sized with a granulator (Power Mill, Showa Chemical Machinery).

向所得整粒物3426g混合硬脂酸钙24g,利用旋转式压片机(HP-AP18-SS:

Figure G2007800281535D00161
鐵工所)将其制造为每1片为230mg的素片。24 g of calcium stearate was mixed with 3426 g of the obtained granules, and a rotary tablet press (HP-AP18-SS:
Figure G2007800281535D00161
Iron Works) manufactures it as plain tablets of 230 mg per tablet.

向所得素片3220g,使用在乙醇1365g溶解、分散有乙基纤维素60g、甲基丙烯酸共聚物L(EudragitL100:樋ロ商会)30g、柠檬酸三乙酯22.5g及轻质硅酸酐22.5g的液体,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)对素片实施控释层后,进而使用在乙醇1410g中溶解、分解有乙基纤维素60g及轻质硅酸酐30g的液体,利用包衣机(ドリアコ一タ一DRC-650、パウレツク)实施控释层,制造每1片为245mg的控释片。To 3220 g of the obtained plain sheet, 60 g of ethyl cellulose, 30 g of methacrylic acid copolymer L (Eudragit L100: Hikou Shokai), 22.5 g of triethyl citrate and 22.5 g of light silicic anhydride were used in 1365 g of ethanol and dispersed therein. For the liquid, after applying a controlled-release layer to the plain tablet using a coating machine (Driacoater-DRC-650, Powrec), a liquid in which 60 g of ethyl cellulose and 30 g of light silicic anhydride were dissolved and decomposed in 1410 g of ethanol was used, A controlled-release layer was applied using a coating machine (Driacoater DRC-650, Powrec) to produce controlled-release tablets of 245 mg per tablet.

<实施例10><Example 10>

对制造例4获得的控释片686g,使用含有砂糖93g、滑石粉3g、沉降碳酸钙51g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)9.9g及精制水135.6g的混悬的糖衣液,利用包衣机(ハイコ一タ一HCT-30N、フロイント产业)喷雾糖衣液、同时进行干燥,获得每1片为295mg(其中糖衣层的质量为50mg)的糖衣片。予以说明,包衣作业所消耗的时间为40分钟。For 686 g of the controlled-release tablets obtained in Production Example 4, 9.9 g of a dispersion containing 93 g of granulated sugar, 3 g of talc, 51 g of precipitated calcium carbonate, and a 30% dispersion of ethyl acrylate/methyl methacrylate copolymer (オイドラギツト NE30D: Hikou Shokai) was used. and purified water 135.6g of the suspended sugar-coating solution, utilize a coating machine (Hicota-HCT-30N, FLOINT INDUSTRY) to spray the sugar-coating solution, and dry simultaneously to obtain 295 mg per tablet (wherein the quality of the sugar-coating layer is 50 mg) ) sugar-coated tablets. It should be noted that the time taken for the coating operation was 40 minutes.

<实施例11><Example 11>

对制造例4获得的控释片686g,使用含有砂糖186g、滑石粉6g、沉降碳酸钙102g、丙烯酸乙酯/甲基丙烯酸甲酯共聚物30%分散液(オイドラギツトNE30D:樋ロ商会)20.1g及精制水270.9g的混悬的糖衣液,利用包衣机(ハイコ一タ一HCT-30N、フロイント产业))喷雾糖衣液、同时进行干燥,获得每1片为345mg(其中糖衣层的质量为100mg)的缓释性糖衣片。予以说明,包衣作业所消耗的时间为75分钟。For 686 g of the controlled-release tablets obtained in Production Example 4, 20.1 g of a dispersion containing 186 g of granulated sugar, 6 g of talc, 102 g of precipitated calcium carbonate, and a 30% dispersion of ethyl acrylate/methyl methacrylate copolymer (オイドラギツト NE30D: Hikou Shokai) was used. and purified water 270.9g of the suspended sugar-coated liquid, utilize a coating machine (Hicota-HCT-30N, FLOINT industry)) to spray the sugar-coated liquid, and dry simultaneously to obtain 345 mg per tablet (wherein the quality of the sugar-coated layer is 100mg) sustained-release sugar-coated tablets. It should be noted that the time taken for the coating operation was 75 minutes.

<比较例7><Comparative example 7>

对制造例4获得的控释片686g,使用含有砂糖288.6g、滑石粉81.3g、沉降碳酸钙122.7g、阿拉伯胶9.6g、明胶4.5g、聚氧乙烯(105)聚氧丙烯(5)二醇3.3g及精制水180g的混悬的糖衣液,利用使用小型糖衣机(菊水制作所制)分别进行糖衣液的喷雾、蒸发、干燥的现有糖衣包衣方法,获得每1片为415mg的底涂片。予以说明,该包衣作业所消耗的时间为300分钟。进而,使用含有砂糖114g、氧化钛6g及精制水72g的混悬的糖衣液,利用使用小型糖衣机(菊水制作所制)分别进行糖衣液的喷雾、蒸发、干燥的现有糖衣包衣方法,获得每1片为455mg的上色片。予以说明,该包衣作业所消耗的时间为240分钟。最后,使用含有砂糖15g及精制水9g的糖衣液,利用使用小型糖衣机(菊水制作所制)分别进行糖衣液的喷雾、蒸发、干燥的现有糖衣包衣方法,获得每1片为460mg(其中糖衣层的质量为215mg)的糖衣片。予以说明,该包衣作业所消耗的时间为30分钟,全部包衣作业所消耗的总时间为570分钟。686 g of controlled-release tablets obtained in Manufacturing Example 4 were prepared by using 288.6 g of granulated sugar, 81.3 g of talcum powder, 122.7 g of precipitated calcium carbonate, 9.6 g of gum arabic, 4.5 g of gelatin, polyoxyethylene (105) polyoxypropylene (5) two Suspended sugar-coating solution of 3.3 g of alcohol and 180 g of purified water was obtained by using the existing sugar-coating method of spraying, evaporating, and drying the sugar-coating solution using a small sugar-coating machine (manufactured by Kikusui Seisakusho) to obtain 415 mg per tablet. Base smear. In addition, the time consumed for this coating operation was 300 minutes. Furthermore, using a suspension sugar coating solution containing 114 g of granulated sugar, 6 g of titanium oxide, and 72 g of purified water, the existing sugar coating method of spraying, evaporating, and drying the sugar coating solution using a small sugar coating machine (manufactured by Kikusui Seisakusho), respectively, Colored tablets of 455 mg per 1 tablet were obtained. In addition, the time consumed for this coating operation was 240 minutes. Finally, using a sugar-coating solution containing 15 g of sugar and 9 g of purified water, the conventional sugar-coating method of spraying, evaporating, and drying the sugar-coating solution using a small sugar-coating machine (manufactured by Kikusui Seisakusho) was used to obtain 460 mg per tablet ( Wherein the quality of sugar-coated layer is the sugar-coated tablet of 215mg). In addition, the time consumed for this coating operation was 30 minutes, and the total time consumed for all coating operations was 570 minutes.

由上述结果可知,使用在喷雾糖衣液的同时进行干燥的本发明制造方法时,与现有的包衣方法相比,可以将作业时间缩短至1/3以下。另外,糖衣片的糖衣层重量也可达到1/2~1/4左右。From the above results, it can be seen that when using the production method of the present invention in which the sugar-coating liquid is sprayed and dried, the working time can be shortened to less than 1/3 compared with the conventional coating method. In addition, the weight of the sugar-coated layer of the sugar-coated tablet can also reach about 1/2 to 1/4.

<吸湿性的评价><Evaluation of Hygroscopicity>

测定将实施例1~9、比较例1~6获得的糖衣片10片在25℃-84.3%条件下静置1小时、2小时、3小时及24小时后的质量,与开始时的质量相比,测定吸湿量,计算吸湿率(%)。另外,测定将实施例10~11、比较例7获得的糖衣片10片在40℃-75%条件下静置3小时、1日、2日、3日、7日、10日、14日、21日、28日及30日后的质量,与上述同样计算吸湿率(%)。结果示于图1~4。Measure the quality of 10 sugar-coated tablets obtained in Examples 1 to 9 and Comparative Examples 1 to 6 at 25° C.-84.3% for 1 hour, 2 hours, 3 hours and 24 hours. Ratio, measure the amount of moisture absorption, and calculate the moisture absorption rate (%). In addition, it was measured that 10 sugar-coated tablets obtained in Examples 10 to 11 and Comparative Example 7 were left to stand at 40°C-75% for 3 hours, 1 day, 2 days, 3 days, 7 days, 10 days, 14 days, For the mass after 21 days, 28 days and 30 days, the moisture absorption rate (%) was calculated in the same manner as above. The results are shown in Figs. 1 to 4 .

吸湿率(%)=(各小时保管后的10片的片剂质量-开始时的10片片剂质量)/开始时的10片的片剂质量×100Moisture absorption rate (%)=(mass of 10 tablets after storage for each hour-mass of 10 tablets at the beginning)/mass of 10 tablets at the beginning×100

由图1可知,实施例1~3的糖衣制剂即便在上述条件下静置24小时,吸湿率也低达0.1%。比较例1的糖衣制剂在静置3小时时,吸湿率达到0.2%,在静置24小时时增加至接近1.2%。另外,比较例2的糖衣制剂在静置24小时时,吸湿率增加至0.5%左右。As can be seen from FIG. 1 , even if the sugar-coated preparations of Examples 1 to 3 were left to stand for 24 hours under the above-mentioned conditions, the moisture absorption rate was as low as 0.1%. The sugar-coated preparation of Comparative Example 1 had a moisture absorption rate of 0.2% when left standing for 3 hours, and increased to nearly 1.2% when left standing for 24 hours. In addition, when the sugar-coated preparation of Comparative Example 2 was left to stand for 24 hours, the moisture absorption rate increased to about 0.5%.

由图2可知,实施例4~6的糖衣制剂即便在上述条件下静置24小时,吸湿率也低达0.1%。比较例3的糖衣制剂在静置3小时时,吸湿率达到0.4%,在静置24小时时增加至接近2.1%。另外,比较例4的糖衣制剂在静置24小时时,吸湿率增加至0.5%左右。As can be seen from FIG. 2 , even if the sugar-coated preparations of Examples 4 to 6 were left to stand for 24 hours under the above-mentioned conditions, the moisture absorption rate was as low as 0.1%. The sugar-coated preparation of Comparative Example 3 had a moisture absorption rate of 0.4% when left standing for 3 hours, and increased to nearly 2.1% when left standing for 24 hours. In addition, when the sugar-coated preparation of Comparative Example 4 was left to stand for 24 hours, the moisture absorption rate increased to about 0.5%.

由图3可知,实施例7~9及比较例6的糖衣制剂即便在上述条件下静置24小时,吸湿率也低达0.5%以下。比较例5的糖衣制剂在静置3小时时,吸湿率增加至接近1.3%,在静置24小时时增加至接近5.6%。As can be seen from FIG. 3 , even if the sugar-coated preparations of Examples 7 to 9 and Comparative Example 6 were left to stand for 24 hours under the above conditions, the moisture absorption rate was as low as 0.5% or less. In the sugar-coated preparation of Comparative Example 5, the moisture absorption rate increased to approximately 1.3% when left to stand for 3 hours, and increased to approximately 5.6% when left to stand for 24 hours.

由图4可知,即便实施例10及11的糖衣制剂的糖衣层质量与比较例7相比分别为约1/4和1/2,30日后的吸湿率也分别达到2.0%及1.0%以下,极低。与此相对,比较例7的糖衣制剂在7日后的阶段,吸湿率接近4.0%,10日后片剂破裂。片剂的破裂可能是由于丙戊酸钠的吸湿性所导致的。It can be seen from FIG. 4 that even though the sugar-coated layer masses of the sugar-coated preparations of Examples 10 and 11 were about 1/4 and 1/2 compared with Comparative Example 7, the moisture absorption rates after 30 days were 2.0% and 1.0%, respectively. extremely low. On the other hand, the sugar-coated preparation of Comparative Example 7 had a moisture absorption rate close to 4.0% after 7 days, and the tablet ruptured after 10 days. Tablet rupture may be due to the hygroscopic nature of sodium valproate.

由以上可知,当使用本发明的糖衣液时,即便是利用在喷雾糖衣液的同时进行干燥的包衣方法制造糖衣制剂时,也可获得与现有的糖衣制剂低吸湿性优异的糖衣制剂。From the above, it can be seen that when the sugar-coating liquid of the present invention is used, even when the sugar-coating preparation is produced by a coating method of drying while spraying the sugar-coating liquid, a sugar-coated preparation having excellent low hygroscopicity compared to conventional sugar-coating preparations can be obtained.

<物性的评价><Evaluation of Physical Properties>

测定实施例1~9、比较例1~6获得的糖衣片的硬度及崩解度。硬度为取20片利用片剂硬度计(PHARMATEST社制PTB-311E)对每1片测定片剂硬度、计算平均值。崩解度为根据日本药局方第15修订所记载的崩解试验法、使用辅助盘进行测定(富山产业社制崩解试验器)。试验对6片进行,计算其平均值。结果示于表1~3。The hardness and disintegration degree of the sugar-coated tablets obtained in Examples 1-9 and Comparative Examples 1-6 were measured. For the hardness, 20 tablets were taken and the tablet hardness was measured for each tablet with a tablet hardness tester (PTB-311E manufactured by Pharmatest Co., Ltd.), and the average value was calculated. The disintegration degree was measured in accordance with the disintegration test method described in the 15th revision of the Japanese Pharmacopoeia using an auxiliary plate (disintegration tester manufactured by Toyama Sangyo Co., Ltd.). The test was carried out on 6 pieces, and the average value was calculated. The results are shown in Tables 1-3.

【表1】【Table 1】

Figure G2007800281535D00181
Figure G2007800281535D00181

实施例1~3的糖衣制剂具有充分的硬度、且崩解性也优异。另一方面,比较例1的糖衣制剂的硬度及崩解性均不充分。比较例2的糖衣制剂虽然具有高硬度,但崩解性不充分。The sugar-coated preparations of Examples 1 to 3 had sufficient hardness and were also excellent in disintegration properties. On the other hand, the sugar-coated preparation of Comparative Example 1 had insufficient hardness and disintegration properties. Although the sugar-coated preparation of Comparative Example 2 had high hardness, its disintegration property was insufficient.

【表2】【Table 2】

实施例4~6的糖衣制剂具有充分的硬度、且崩解性也优异。另一方面,比较例3的糖衣制剂的硬度及崩解性均不充分。比较例4的糖衣制剂虽然具有高硬度,但崩解性不足。The sugar-coated preparations of Examples 4 to 6 had sufficient hardness and were also excellent in disintegration properties. On the other hand, the sugar-coated preparation of Comparative Example 3 had insufficient hardness and disintegration properties. Although the sugar-coated preparation of Comparative Example 4 had high hardness, disintegration was insufficient.

【表3】【table 3】

Figure G2007800281535D00191
Figure G2007800281535D00191

实施例7~9的糖衣制剂具有充分的硬度、且崩解性也优异。另一方面,比较例5及6的糖衣制剂的硬度或崩解性不充分。The sugar-coated preparations of Examples 7 to 9 had sufficient hardness and were also excellent in disintegration properties. On the other hand, the sugar-coated preparations of Comparative Examples 5 and 6 had insufficient hardness and disintegration properties.

由以上可知,本发明的糖衣制剂具有充分的硬度、且崩解性也优异。From the above, it can be seen that the sugar-coated preparation of the present invention has sufficient hardness and is also excellent in disintegration properties.

<气味的评价><Evaluation of smell>

对实施例4~9、比较例3~6获得的糖衣片的气味进行评价。将所得制剂放入透明玻璃瓶进行密封后,对在60℃的条件下保存3日、1周及2周时的气味的发生,按照以下4等级进行评价,0:完全感觉不到来自药物的不愉快气味、1:基本感觉不到来自药物的不愉快气味、2:感觉到来自药物的不愉快气味、3:强烈感觉到来自药物的不愉快气味。评价为5个人进行,计算平均值。结果示于表4~5。The odor of the sugar-coated tablets obtained in Examples 4-9 and Comparative Examples 3-6 was evaluated. After putting the obtained preparation into a transparent glass bottle and sealing it, the occurrence of odor when stored at 60°C for 3 days, 1 week, and 2 weeks was evaluated according to the following 4 levels, 0: No odor from the drug was felt at all. Unpleasant smell, 1: The unpleasant smell derived from the drug is hardly felt, 2: The unpleasant smell derived from the drug is sensed, 3: The unpleasant smell derived from the drug is strongly felt. The evaluation was performed by 5 persons, and the average value was calculated. The results are shown in Tables 4-5.

【表4】【Table 4】

Figure G2007800281535D00192
Figure G2007800281535D00192

实施例4~6和比较例4的糖衣制剂即便经过2周的保存期间,也完全感觉不到来自オキソアミヂン的不愉快气味。另一方面,比较例3的糖衣制剂强烈地感到オキソアミヂン来源的不愉快气味。特别是随着保存延长,不愉快气味加强。In the sugar-coated preparations of Examples 4 to 6 and Comparative Example 4, the unpleasant smell derived from okisoamina was not sensed at all even after a 2-week storage period. On the other hand, the sugar-coated preparation of Comparative Example 3 had a strong unpleasant smell derived from okisoamina. Especially with prolonged storage, the unpleasant smell intensifies.

【表5】【table 5】

Figure G2007800281535D00201
Figure G2007800281535D00201

实施例7~9和比较例6的糖衣制剂即便经过2周的保存期间,也基本感觉不到来自MMSC的不愉快气味。另一方面,比较例5的糖衣制剂在3天后感到来自MMSC的不愉快气味,在1周后强烈地感觉到不愉快气味。In the sugar-coated preparations of Examples 7 to 9 and Comparative Example 6, even after a 2-week storage period, the unpleasant smell derived from MMSC was hardly felt. On the other hand, in the sugar-coated preparation of Comparative Example 5, the unpleasant smell derived from MMSC was felt after 3 days, and the unpleasant smell was strongly felt after 1 week.

由以上可知,本发明的糖衣制剂与现有的糖衣制剂相比,防臭性更为优异。From the above, it can be seen that the sugar-coated preparation of the present invention is more excellent in deodorant property than the conventional sugar-coated preparation.

<刚制造后的水分值评价><Moisture value evaluation immediately after manufacture>

粉碎刚制造后的实施例7~9、比较例5~6的糖衣片,称量约5g,作为反应试剂使用氢氧化钙,利用气压水分计测定10分钟,计算水分值(%)。结果示于表6。The sugar-coated tablets of Examples 7 to 9 and Comparative Examples 5 to 6 immediately after manufacture were pulverized, about 5 g was weighed, calcium hydroxide was used as a reaction reagent, and the water content (%) was calculated by measuring with a barometric moisture meter for 10 minutes. The results are shown in Table 6.

【表6】【Table 6】

Figure G2007800281535D00202
Figure G2007800281535D00202

实施例7~9及比较例5的糖衣制剂的水分值(%)与比较例6的糖衣制剂相比,为更低的数值。因此,当使用连续包衣法时,与现有的包衣方法相比,可以降低片剂中的水分值。The water content (%) of the sugar-coated preparations of Examples 7-9 and Comparative Example 5 was lower than that of the sugar-coated preparation of Comparative Example 6. Therefore, when using the continuous coating method, the moisture value in the tablet can be reduced compared to the existing coating method.

<溶出试验><Dissolution test>

进行实施例11的糖衣片的溶出试验。试验如下进行:利用日本药局方溶出试验法第二法(桨法),作为试验液使用日局一般试验法崩解试验法第2液500mL,在每分100rpm下进行。每个小时进行采样,利用HPLC定量采样溶液中的丙戊酸钠,计算丙戊酸钠的溶出率(%)。结果示于图5。The dissolution test of the sugar-coated tablet of Example 11 was carried out. The test was carried out by using Japanese Pharmacopoeia Prescription Dissolution Test Method 2 (paddle method) and using 500 mL of Japanese Pharmacopoeia General Test Method Disintegration Test Method 2 Liquid as the test solution at 100 rpm per minute. Sampling was carried out every hour, and sodium valproate in the quantitative sampling solution was utilized by HPLC to calculate the dissolution rate (%) of sodium valproate. The results are shown in Figure 5.

由图5可知,本申请发明的糖衣制剂的缓释性也优异。由上可知,本发明的糖衣液对于需要缓释性的药物的糖衣制剂化也有用。As can be seen from FIG. 5 , the sugar-coated formulation of the present invention is also excellent in sustained release. From the above, it can be seen that the sugar-coated solution of the present invention is also useful for sugar-coated formulations of drugs requiring sustained release.

由以上可知,本发明的糖衣制剂与利用连续包衣法制造的现有糖衣制剂相比,为具有充分硬度、且低吸湿性、防臭性优异的制剂,与利用糖衣包衣法制造的现有糖衣制剂相比,能够以短时间的包衣作业制造,是刚制造后的水分值低、崩解性优异的制剂。As can be seen from the above, the sugar-coated preparation of the present invention has sufficient hardness, low hygroscopicity, and excellent deodorization compared with the conventional sugar-coated preparation produced by the continuous coating method. Compared with sugar-coated preparations, it can be produced in a short coating operation, and it is a preparation with a low moisture content immediately after production and excellent disintegration properties.

即,通过本发明的制造方法,可以短时间且简单地制造糖衣层虽然薄、但具有充分硬度、且刚制造后的低水分性、低吸湿性、崩解性、防臭性优异的糖衣制剂。That is, according to the production method of the present invention, a sugar-coated preparation that has a thin sugar-coated layer but has sufficient hardness and is excellent in low water content, low hygroscopicity, disintegration property, and deodorant property immediately after production can be easily produced in a short time.

产业实用性Industrial applicability

使用本发明的糖衣液,利用同时进行糖衣液的喷雾工序及干燥工序的连续包衣法可以进行糖衣制剂的制造。即,可以在不需要复杂工序的情况下,短时间地制造低透氧性、低吸湿性、防臭性、崩解性优异的糖衣制剂。另外,本发明的制造方法由于能够形成薄的糖衣层,因此大大有助于糖衣液使用量的减少、制剂的小型化。Sugar-coated preparations can be produced by using the sugar-coated solution of the present invention by a continuous coating method in which a spraying step and a drying step of the sugar-coated solution are performed simultaneously. That is, a sugar-coated preparation excellent in low oxygen permeability, low hygroscopicity, deodorant property, and disintegration property can be produced in a short time without requiring complicated steps. In addition, since the production method of the present invention can form a thin sugar-coated layer, it greatly contributes to the reduction of the amount of sugar-coated solution used and the miniaturization of the formulation.

Claims (5)

1.一种糖衣液,其为含有糖、丙烯酸乙酯/甲基丙烯酸甲酯共聚物及溶剂的糖衣液,丙烯酸乙酯/甲基丙烯酸甲酯共聚物的浓度相对于总固态成分为0.01~10重量%,丙烯酸乙酯/甲基丙烯酸甲酯共聚物与糖的质量比为1∶5~1∶500,丙烯酸乙酯/甲基丙烯酸甲酯共聚物的数均分子量为500,000~1,100,000,丙烯酸乙酯/甲基丙烯酸甲酯共聚物中,丙烯酸乙酯与甲基丙烯酸甲酯的摩尔比为3∶1~1∶3。1. A sugar-coating liquid, which is a sugar-coating liquid containing sugar, ethyl acrylate/methyl methacrylate copolymer and solvent, the concentration of ethyl acrylate/methyl methacrylate copolymer is 0.01~ 10% by weight, the mass ratio of ethyl acrylate/methyl methacrylate copolymer to sugar is 1:5~1:500, the number average molecular weight of ethyl acrylate/methyl methacrylate copolymer is 500,000~1,100,000, acrylic acid In the ethyl ester/methyl methacrylate copolymer, the molar ratio of ethyl acrylate to methyl methacrylate is 3:1-1:3. 2.一种糖衣制剂,其为具有含有药物的芯材以及包覆该芯材的糖衣层的糖衣制剂,其特征在于,该糖衣层的至少1层含有糖及0.01~10重量%丙烯酸乙酯/甲基丙烯酸甲酯共聚物,丙烯酸乙酯/甲基丙烯酸甲酯共聚物与糖的质量比为1∶5~1∶500,丙烯酸乙酯/甲基丙烯酸甲酯共聚物的数均分子量为500,000~1,100,000,丙烯酸乙酯/甲基丙烯酸甲酯共聚物中,丙烯酸乙酯与甲基丙烯酸甲酯的摩尔比为3∶1~1∶3。2. A sugar-coated preparation comprising a drug-containing core material and a sugar-coated layer covering the core material, wherein at least one of the sugar-coated layers contains sugar and 0.01 to 10% by weight of ethyl acrylate /methyl methacrylate copolymer, the mass ratio of ethyl acrylate/methyl methacrylate copolymer to sugar is 1:5~1:500, and the number average molecular weight of ethyl acrylate/methyl methacrylate copolymer is 500,000~1,100,000, in ethyl acrylate/methyl methacrylate copolymer, the molar ratio of ethyl acrylate to methyl methacrylate is 3:1~1:3. 3.如权利要求2所述的糖衣制剂,其特征在于,进一步具有控释层。3. The sugar-coated preparation according to claim 2, further comprising a release-controlling layer. 4.如权利要求2或3所述的糖衣制剂,其特征在于,药物为具有不愉快气味的药物、对水分不稳定的药物或者产生须晶的药物。4. The sugar-coated preparation according to claim 2 or 3, wherein the medicine is a medicine having an unpleasant smell, a medicine unstable to moisture, or a medicine producing whiskers. 5.一种糖衣制剂的制造方法,其特征在于,同时进行权利要求1所述的糖衣液的喷雾工序及干燥工序。5. A method for producing a sugar-coated preparation, wherein the spraying step and the drying step of the sugar-coating liquid according to claim 1 are performed simultaneously.
CN2007800281535A 2006-07-25 2007-07-18 Sugar-coated preparation and its manufacturing method Expired - Fee Related CN101495101B (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2006201731 2006-07-25
JP201731/2006 2006-07-25
JP2006308050 2006-11-14
JP308050/2006 2006-11-14
JP2006338547 2006-12-15
JP338547/2006 2006-12-15
JP2007132001 2007-05-17
JP132001/2007 2007-05-17
PCT/JP2007/064152 WO2008013084A1 (en) 2006-07-25 2007-07-18 Sugar-coated preparation and process for producing the same

Publications (2)

Publication Number Publication Date
CN101495101A CN101495101A (en) 2009-07-29
CN101495101B true CN101495101B (en) 2012-02-29

Family

ID=38981396

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800281535A Expired - Fee Related CN101495101B (en) 2006-07-25 2007-07-18 Sugar-coated preparation and its manufacturing method

Country Status (6)

Country Link
JP (3) JPWO2008013084A1 (en)
KR (1) KR20090037951A (en)
CN (1) CN101495101B (en)
HK (1) HK1132664A1 (en)
TW (1) TW200812571A (en)
WO (1) WO2008013084A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803686B2 (en) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 Granules and orally disintegrating tablets containing a bitter-tasting drug
CN104367625A (en) * 2014-11-03 2015-02-25 成都森科制药有限公司 Method for preparing selfheal tablet
FR3067567B1 (en) * 2017-06-19 2019-07-05 Roquette Freres NEW DRAGEIFICATION PROCESS AND DRAGED SOLID FORMS HAVING IRREGULAR SHAPES

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039542A1 (en) * 2003-10-27 2005-05-06 Yamanouchi Pharmaceutical Co., Ltd. Drug-containing coated microparticle for orally disintegrating tablet
WO2005120466A2 (en) * 2004-06-07 2005-12-22 Wyeth Sugar coatings and methods therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449384A1 (en) * 1974-10-17 1976-04-29 Roehm Gmbh METHOD OF MANUFACTURING MEDICINAL CONES
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5244224A (en) * 1975-10-01 1977-04-07 Yamanouchi Pharmaceut Co Ltd Printing on sugar-coated tablets
CH666405A5 (en) * 1985-06-24 1988-07-29 Ciba Geigy Ag SOLID, DURABLE PHARMACEUTICAL FORMS WITH ELASTIC FILM COVER.
JPS64421A (en) * 1987-06-23 1989-01-05 Kurita Water Ind Ltd Flow rate measuring instrument
DE19615812A1 (en) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmaceutical preparation containing diphosphonic acids for oral administration
JP2004010611A (en) * 2002-06-06 2004-01-15 Nisshin Yakuhin Kogyo Kk Masking composition
JP2004155656A (en) * 2002-11-01 2004-06-03 Kao Corp Sugar-coated tablet
WO2004108164A1 (en) * 2003-06-04 2004-12-16 Kyowa Hakko Kogyo Co., Ltd. Composition for coating and coated preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039542A1 (en) * 2003-10-27 2005-05-06 Yamanouchi Pharmaceutical Co., Ltd. Drug-containing coated microparticle for orally disintegrating tablet
WO2005120466A2 (en) * 2004-06-07 2005-12-22 Wyeth Sugar coatings and methods therefor

Also Published As

Publication number Publication date
KR20090037951A (en) 2009-04-16
CN101495101A (en) 2009-07-29
JPWO2008013084A1 (en) 2009-12-17
HK1132664A1 (en) 2010-03-05
TW200812571A (en) 2008-03-16
JP2014221847A (en) 2014-11-27
JP2013100365A (en) 2013-05-23
WO2008013084A1 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
CN101987081B (en) Controlled release preparation
CN101180046B (en) Stable tablet containing droxidopa
JP6521564B2 (en) Solid coated dosage form with rapid collapse
US20040136923A1 (en) Edible film for relief of cough or symptoms associated with pharyngitis
PT1459740E (en) Compositions containing sucralose
WO2007074856A1 (en) Method of producing solid preparation disintegrating in the oral cavity
CN107823189A (en) A kind of chlorination potassium sustained-release pellet and preparation method and application
CN105832687A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
KR102687595B1 (en) A composition for the outer layer of a solid preparation and an easy-to-take solid preparation comprising the composition for the outer layer
JPWO2013115171A1 (en) Orally disintegrating tablets containing bitter mask granules
US20100266687A1 (en) Improved tablet coating
CN114917205A (en) Oral dissolving film composition
CN101985044B (en) Taste-masking medicinal coating composition
CN101495101B (en) Sugar-coated preparation and its manufacturing method
CN102258490B (en) Ibuprofen chewable tablet
CN102000344B (en) Medicament coating composition with masked taste
EP3345626A1 (en) Super-rapid disintegrating tablet, and method for producing same
WO2005049048A1 (en) Fiber rich fraction of trigonella foenum-graecum and its use as a pharmaceutcal excipient
KR101680925B1 (en) Unpleasant taste-masking particles and an oral preparation containing same
KR20170001786A (en) Preparation method for pharmaceutical composition comprising Pelargonium sidoides extracts
CN115006363A (en) A kind of oyster calcium carbonate chewable tablet and preparation method thereof
JP2022161887A (en) Solid pharmaceutical composition
CN101637443A (en) Solid preparation containing cysteine with reduced smell
TW200824708A (en) Solid composition
CN104856992A (en) Pharmaceutical composition of rabeprazole

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1132664

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1132664

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120229

Termination date: 20190718